: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Inflammatory Bowel Diseases

Free Subscription

Articles published in J Crohns Colitis
Retrieve available abstracts of 742 articles:
HTML format

Single Articles

April 2024

PETIT P, Leroyer A, Chamot S, Fumery M, et al
Farming activities and risk of inflammatory bowel disease: a French nationwide population-based cohort study.
J Crohns Colitis. 2024 Apr 12:jjae050. doi: 10.1093.
PubMed Abstract available

MOHAMEDRASHED M, Garg M, Bohra A
Advocating for Consensus: The crucial role of standardised Magnetic resonance imaging (MRE) protocols and image quality metrics in assessment of Crohn's disease.
J Crohns Colitis. 2024 Apr 12:jjae051. doi: 10.1093.
PubMed

TIONG HT, Fan D, Frampton C, Ananthakrishnan AN, et al
Physical Activity Is Associated With A Decreased Risk Of Developing Inflammatory Bowel Disease: A Systematic Review And Meta-Analysis.
J Crohns Colitis. 2024 Apr 10:jjae053. doi: 10.1093.
PubMed Abstract available

ZADORA W, Innocenti T, Verstockt B, Meijers B, et al
Chronic kidney disease in inflammatory bowel disease, a systematic review and meta-analysis.
J Crohns Colitis. 2024 Apr 8:jjae049. doi: 10.1093.
PubMed Abstract available

MERTZ NORGARD B, Garvik OS, Zegers FD, Nielsen J, et al
New surgery and hospital-diagnosed infections in elderly patients with inflammatory bowel disease undergoing surgery - a nationwide cohort study.
J Crohns Colitis. 2024 Apr 5:jjae047. doi: 10.1093.
PubMed Abstract available

VAN LINGEN E, Nooij S, Terveer E, Crossette E, et al
Fecal Microbiota Transplantation engraftment after budesonide or placebo in patients with active ulcerative colitis using pre-selected donors: a randomized pilot study.
J Crohns Colitis. 2024 Apr 4:jjae043. doi: 10.1093.
PubMed Abstract available

March 2024

KUMAR S, De Kock I, Blad W, Hare R, et al
Magnetic resonance enterography and intestinal ultrasound for the assessment and monitoring of Crohn's disease.
J Crohns Colitis. 2024 Mar 30:jjae042. doi: 10.1093.
PubMed Abstract available

VAN DEN HOUTE M, Guadagnoli L, Ohman L, Bergstedt A, et al
Predictors of symptom trajectory in newly diagnosed ulcerative colitis: a 3-year follow-up cohort study.
J Crohns Colitis. 2024 Mar 29:jjae046. doi: 10.1093.
PubMed Abstract available

CUNHA MF, Roseira J
Letter to the Editor regarding the article Minimally invasive surgery for Inflammatory Bowel Disease: a systematic review and meta-analysis of robotic versus laparoscopic surgical techniques.
J Crohns Colitis. 2024 Mar 28:jjae045. doi: 10.1093.
PubMed

SCIBERRAS M, Farrugia Y, Gordon H, Furfaro F, et al
Accuracy of Information given by ChatGPT for patients with Inflammatory Bowel Disease in relation to ECCO Guidelines.
J Crohns Colitis. 2024 Mar 23:jjae040. doi: 10.1093.
PubMed Abstract available

SHRESTHA S, Brand JS, Osooli M, Eriksson C, et al
Spondyloarthritis in first-degree relatives and spouses of patients with inflammatory bowel disease: A nationwide population-based cohort study from Sweden.
J Crohns Colitis. 2024 Mar 22:jjae041. doi: 10.1093.
PubMed Abstract available

Corrigendum to: Influence of Early Life Factors, including breast milk Composition, on the Microbiome of Infants Born to Mothers with and without Inflammatory Bowel Disease.
J Crohns Colitis. 2024 Mar 20:jjae021. doi: 10.1093.
PubMed

VAN GENNEP S, Fung ICN, de Jong DC, Ramkisoen RK, et al
Histological Outcomes And Jak-Stat Signalling In Ulcerative Colitis Patients Treated With Tofacitinib.
J Crohns Colitis. 2024 Mar 20:jjae031. doi: 10.1093.
PubMed Abstract available

CON D, Hilley P, Chin S, Corte C, et al
Safety and effectiveness of Janus kinase inhibitors in the management of inflammatory bowel disease following liver transplantation.
J Crohns Colitis. 2024 Mar 19:jjae039. doi: 10.1093.
PubMed Abstract available

FUNG M, Farbod Y, Kankouni H, Singh S, et al
Does combined medical and surgical treatment improve perianal fistula outcomes in patients with Crohn's disease? A systematic review and meta-analysis.
J Crohns Colitis. 2024 Mar 16:jjae035. doi: 10.1093.
PubMed Abstract available

GENG Z, Li J, Zuo L, Zhang X, et al
Intestinal adipocytes transdifferentiate into myofibroblast-like cells and contribute to fibrosis in Crohn's disease.
J Crohns Colitis. 2024 Mar 11:jjae036. doi: 10.1093.
PubMed Abstract available

ZAMAN S, Mohamedahmed AYY, Abdelrahman W, Abdalla HE, et al
Minimally invasive surgery for Inflammatory Bowel Disease: a systematic review and meta-analysis of robotic versus laparoscopic surgical techniques.
J Crohns Colitis. 2024 Mar 11:jjae037. doi: 10.1093.
PubMed Abstract available

LEHMANN M, Weixler B, Elezkurtaj S, Loddenkemper C, et al
Spatial single cell profiling using imaging mass cytometry - inflammatory versus penetrating Crohn's disease.
J Crohns Colitis. 2024 Mar 11:jjae033. doi: 10.1093.
PubMed Abstract available

ELLRICHMANN M, Schulte B, Conrad CC, Schoch S, et al
Contrast enhanced endoscopic ultrasound detects early therapy response following anti-TNF-therapy in patients with ulcerative colitis.
J Crohns Colitis. 2024 Mar 8:jjae034. doi: 10.1093.
PubMed Abstract available

TEUGELS A, van den Eijnden I, Keersmaekers B, Verstockt B, et al
Disease acceptance, but not perceived control, is uniquely associated with inflammatory bowel disease-related disability.
J Crohns Colitis. 2024 Mar 6:jjae025. doi: 10.1093.
PubMed Abstract available

BIEL C, Faber KN, Bank RA, Olinga P, et al
Matrix metalloproteinases in intestinal fibrosis.
J Crohns Colitis. 2024;18:462-478.
PubMed Abstract available

WARSOP ZI, Manzo CA, Yu N, Yusuf B, et al
Patient-reported Outcome Measures in Ileoanal Pouch Surgery: a Systematic Review.
J Crohns Colitis. 2024;18:479-487.
PubMed Abstract available

JOJART B, Resal T, Kata D, Molnar T, et al
Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases.
J Crohns Colitis. 2024;18:392-405.
PubMed Abstract available

WEBER S, Sitte S, Voegele AL, Sologub L, et al
NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel Diseases.
J Crohns Colitis. 2024;18:446-461.
PubMed Abstract available

February 2024

ROSH JR, Turner D, Hyams JS, Dubinsky M, et al
Outcomes in Adult Inflammatory Bowel Disease Clinical Trials: Assessment of Similarity Among Participants with Adolescent-Onset and Adult-Onset Disease.
J Crohns Colitis. 2024 Feb 26:jjae030. doi: 10.1093.
PubMed Abstract available

TORRES J, Colombel JF, Mary JY
Lemman Index in Children: Still an Open Question.
J Crohns Colitis. 2024;18:331-332.
PubMed

GEBEYEHU GG, Taylor F, Dobson L, Cummings JRF, et al
Validation of the IBD-Control Questionnaire across different sociodemographic and clinical subgroups: secondary analysis of a nationwide electronic survey.
J Crohns Colitis. 2024;18:275-285.
PubMed Abstract available

GRANT RK, Jones GR, Plevris N, Lynch RW, et al
Validation of the ACE [Albumin, CRP, and Endoscopy] Index in Acute Colitis: Analysis of the CONSTRUCT dataset.
J Crohns Colitis. 2024;18:286-290.
PubMed Abstract available

DHALIWAL J, Tertigas D, Carman N, Lawrence S, et al
Outcomes Following Acute Severe Colitis at Initial Presentation: A Multi-centre, Prospective, Paediatric Cohort Study.
J Crohns Colitis. 2024;18:233-245.
PubMed Abstract available

LO B, Biederman L, Rogler G, Dora B, et al
Specific antibiotics increases the risk of flare-ups in patients with inflammatory bowel disease - results from a Danish nationwide population-based nested case-control study.
J Crohns Colitis. 2024 Feb 17:jjae027. doi: 10.1093.
PubMed Abstract available

ARJOMAND FARD N, Wine E
Clostridium perfringens: A Potential Pathobiont in Inflammatory Bowel Disease.
J Crohns Colitis. 2024 Feb 16:jjae019. doi: 10.1093.
PubMed

KOELINK PJ, Gomez-Mellado VE, Duijst S, van Roest M, et al
The phospholipid flippase ATP8B1 is involved in the pathogenesis of Ulcerative Colitis via establishment of intestinal barrier function.
J Crohns Colitis. 2024 Feb 16:jjae024. doi: 10.1093.
PubMed Abstract available

REINISCH W, Colombel JF, D'Haens GR, Rimola J, et al
Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulizing Crohn's Disease [DIVERGENCE 2]: a Phase 2, Randomized, Placebo-Controlled Trial.
J Crohns Colitis. 2024 Feb 16:jjae003. doi: 10.1093.
PubMed Abstract available

PRENTICE R, Flanagan E, Wright E, Prideaux L, et al
Thiopurine metabolite shunting in late pregnancy increases the risk of intrahepatic cholestasis of pregnancy in women with inflammatory bowel disease, and can be managed with split-dosing.
J Crohns Colitis. 2024 Feb 15:jjae023. doi: 10.1093.
PubMed Abstract available

VLADIMIROVA N, Terslev L, Attauabi M, Madsen G, et al
Peripheral joint and enthesis involvement in patients with newly diagnosed inflammatory bowel disease: symptoms, clinical and ultrasound findings - a population-based cohort study.
J Crohns Colitis. 2024 Feb 15:jjae022. doi: 10.1093.
PubMed Abstract available

SIGVARDSSON I, Ludvigsson J, Andersson B, Stordal K, et al
Tobacco smoke exposure in early childhood and later risk of inflammatory bowel disease: A Scandinavian birth cohort study.
J Crohns Colitis. 2024 Feb 8:jjae020. doi: 10.1093.
PubMed Abstract available

GHOSH S, Feagan BG, Ott E, Gasink C, et al
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis.
J Crohns Colitis. 2024 Feb 4:jjae013. doi: 10.1093.
PubMed Abstract available

January 2024

KUO J, Uzunovic J, Jacobson A, Dourado M, et al
Toxigenic Clostridium perfringens isolated from at-risk pediatric inflammatory bowel disease patients.
J Crohns Colitis. 2024 Jan 24:jjae016. doi: 10.1093.
PubMed Abstract available

DUAN M, Lu M, Diao Y, Cao L, et al
Azathioprine plus exclusive enteral nutrition versus azathioprine monotherapy for the prevention of postoperative recurrence in patients with Crohn's disease: an open-label, single-centre, randomised controlled trial.
J Crohns Colitis. 2024 Jan 22:jjae015. doi: 10.1093.
PubMed Abstract available

YARUR AJ, Chiorean MV, Panes J, Jairath V, et al
Achievement of clinical, endoscopic, and histologic outcomes in patients with ulcerative colitis treated with etrasimod, and association with fecal calprotectin and C-reactive protein: results from the Phase 2 OASIS trial.
J Crohns Colitis. 2024 Jan 20:jjae007. doi: 10.1093.
PubMed Abstract available

MAGRO F, Fernandes S, Patita M, Arroja B, et al
The influence of subclinical active inflammation on IFX pharmacokinetic modeling and disease progression assessment: findings from a prospective real-world study in inflammatory bowel disease patients.
J Crohns Colitis. 2024 Jan 19:jjae014. doi: 10.1093.
PubMed Abstract available

Erratum to: Ustekinumab as Induction and Maintenance Therapy in Patients with Inflammatory Bowel Disease and Type II Autoimmune Pancreatitis: Report of Two Cases.
J Crohns Colitis. 2024 Jan 19:jjae005. doi: 10.1093.
PubMed

BITTERLIN T, Valibouze C, Lenne X, Bruandet A, et al
Hospital surgical volume-outcome relationship of postoperative morbidity for ileocolic resection in Crohn's disease: A French nationwide study of 4,205 patients.
J Crohns Colitis. 2024 Jan 18:jjae010. doi: 10.1093.
PubMed Abstract available

CHULKINA M, Rohmer C, McAninch S, Panganiban RP, et al
Increased activity of MAPKAPK2 within mesenchymal cells as a target for inflammation associated fibrosis in Crohn's Disease.
J Crohns Colitis. 2024 Jan 15:jjae009. doi: 10.1093.
PubMed Abstract available

DESAI A, Hashash JG, Kochhar GS, Hayney MS, et al
Recombinant Zoster Vaccine (RZV) is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study.
J Crohns Colitis. 2024 Jan 15:jjae008. doi: 10.1093.
PubMed Abstract available

RODRIGUEZ-ALCOLADO L, Grueso-Navarro E, Arias A, Lucendo AJ, et al
Impact of HLA-DQA1 *05 Genotype in Immunogenicity and Failure to Treatment with Tumor Necrosis Factor-alpha Antagonists in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
J Crohns Colitis. 2024 Jan 14:jjae006. doi: 10.1093.
PubMed Abstract available

WONG C, van Oostrom J, Pittet V, Bossuyt P, et al
Baseline Data and Measurement Instruments Reported In Observational Studies In Inflammatory Bowel Disease: Results From A Systematic Review.
J Crohns Colitis. 2024 Jan 12:jjae004. doi: 10.1093.
PubMed Abstract available

TIMAR AE, Parniczky A, Budai KA, Hernadfoi MV, et al
Beyond the Gut: A Systematic Review and Meta-analysis of Advanced Therapies for Inflammatory Bowel Disease-associated Extraintestinal Manifestations.
J Crohns Colitis. 2024 Jan 8:jjae002. doi: 10.1093.
PubMed Abstract available

PRUIJT MJ, de Voogd FAE, Montazeri NSM, van Etten-Jamaludin FS, et al
DIAGNOSTIC ACCURACY OF INTESTINAL ULTRASOUND IN THE DETECTION OF INTRA-ABDOMINAL COMPLICATIONS IN CROHN'S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
J Crohns Colitis. 2024 Jan 4:jjad215. doi: 10.1093.
PubMed Abstract available

December 2023

TAL N, Tzivinikos C, Gasparetto M, Serban DE, et al
Clinical Features and Natural History of Paediatric Patients with Ulcerative Proctitis: A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN.
J Crohns Colitis. 2023;17:1939-1948.
PubMed Abstract available

HASSAN-ZAHRAEE M, Ye Z, Xi L, Dushin E, et al
Baseline serum and stool microbiome biomarkers predict clinical efficacy and tissue molecular response after ritlecitinib induction therapy in ulcerative colitis.
J Crohns Colitis. 2023 Dec 23:jjad213. doi: 10.1093.
PubMed Abstract available

DOLINGER MT, Aronskyy I, Kellar A, Spencer E, et al
Early Intestinal Ultrasound Response to Biologic Therapy Predicts Endoscopic Remission in Children with Ileal Crohn's Disease: Results from the Prospective Super Sonic Study.
J Crohns Colitis. 2023 Dec 23:jjad216. doi: 10.1093.
PubMed Abstract available

Correction to: Female and Male Fertility after Colectomy and Reconstructive Surgery in Inflammatory Bowel Disease: A National Cohort Study from Sweden.
J Crohns Colitis. 2023 Dec 23:jjad210. doi: 10.1093.
PubMed

VUYYURU SK, Solitano V, Singh S, Hanzel J, et al
Scoring indices for perianal fistulizing Crohn's disease: A systematic review.
J Crohns Colitis. 2023 Dec 21:jjad214. doi: 10.1093.
PubMed Abstract available

HAMMOUDI N, Sachar D, D'Haens G, Reinisch W, et al
Outcomes and endpoints of postoperative recurrence in Crohn's Disease: systematic review and consensus conference.
J Crohns Colitis. 2023 Dec 19:jjad205. doi: 10.1093.
PubMed Abstract available

NIEVA C, Pryor J, Williams GM, Hoedt EC, et al
The Impact of Dietary Interventions on the Microbiota in Inflammatory Bowel Disease: A Systematic Review.
J Crohns Colitis. 2023 Dec 15:jjad204. doi: 10.1093.
PubMed Abstract available

VERMEIRE S, Danese S, Sandborn WJ, Schreiber S, et al
Efficacy and Safety of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease.
J Crohns Colitis. 2023 Dec 14:jjad199. doi: 10.1093.
PubMed Abstract available

LEWIS A, Humphreys DT, Pan-Castillo B, Berti G, et al
Epigenetic and metabolic reprogramming of fibroblasts in Crohn's disease strictures reveals histone deacetylases as therapeutic targets.
J Crohns Colitis. 2023 Dec 9:jjad209. doi: 10.1093.
PubMed Abstract available

COLOMBEL JF, Schreiber S, D'Haens G, Rizzo J, et al
Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn's Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 Studies.
J Crohns Colitis. 2023 Dec 9:jjad206. doi: 10.1093.
PubMed Abstract available

GROS B, Goodall M, Plevris N, Constantine-Cooke N, et al
Real-World Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis.
J Crohns Colitis. 2023 Dec 8:jjad187. doi: 10.1093.
PubMed Abstract available

KAPIZIONI C, Desoki R, Lam D, Balendran K, et al
Biologic therapy for inflammatory bowel disease: Real-world comparative effectiveness and impact of drug sequencing in 13,222 patients within the UK IBD BioResource.
J Crohns Colitis. 2023 Dec 2:jjad203. doi: 10.1093.
PubMed Abstract available

VAN DER DOES DE WILLEBOIS EML, Sari C, Mookhoek A, Joustra V, et al
The clinical relevance of an inflamed appendix in Crohn's disease.
J Crohns Colitis. 2023 Dec 1:jjad202. doi: 10.1093.
PubMed Abstract available

HU L, Wu S, Shu Y, Su K, et al
Impact of Maternal Smoking, Offspring Smoking, and Genetic Susceptibility on Crohn's Disease and Ulcerative Colitis.
J Crohns Colitis. 2023 Dec 1:jjad200. doi: 10.1093.
PubMed Abstract available

November 2023

WATANABE K, Peyrin-Biroulet L, Danese S, Fujitani Y, et al
Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post hoc Analysis of the Phase 2b/3 SELECTION Study.
J Crohns Colitis. 2023 Nov 29:jjad201. doi: 10.1093.
PubMed Abstract available

KLOMBERG RCW, van der Wal HC, Aardoom MA, Kemos P, et al
Improved clinical outcomes with early anti-tumour necrosis factor alpha therapy in children with newly diagnosed Crohn's disease: real world data from the international prospective PIBD-SETQuality inception cohort study.
J Crohns Colitis. 2023 Nov 27:jjad197. doi: 10.1093.
PubMed Abstract available

SCHELLENBERG C, Lagrange J, Ahmed MU, Arnone D, et al
The role of platelets and von Willebrand factor in the procoagulant phenotype of inflammatory bowel disease.
J Crohns Colitis. 2023 Nov 27:jjad198. doi: 10.1093.
PubMed Abstract available

WANG Y, He Q, Yao D, Huang Y, et al
Histologic image-based ensemble model to identify myenteric plexitis and predict endoscopic postoperative recurrence in Crohn's disease: a multicentre, retrospective study.
J Crohns Colitis. 2023 Nov 24:jjad196. doi: 10.1093.
PubMed Abstract available

BISHU S
Nurturing the Gut, Moms with IBD and Their Babies.
J Crohns Colitis. 2023;17:1705-1706.
PubMed

DORK R, Pelczar P, Shiri AM, Volmari A, et al
Myeloid Cell-Specific Deletion of PDGFR-alpha Promotes Dysbiotic Intestinal Microbiota and thus Increased Colitis Susceptibility.
J Crohns Colitis. 2023;17:1858-1869.
PubMed Abstract available

PUGLIESE N, Dal Buono A, Armuzzi A
Unveiling the Complexity of Porto-Sinusoidal Vascular Disorder in Inflammatory Bowel Disease: A Call for Further Investigation.
J Crohns Colitis. 2023;17:1892.
PubMed

REVES J, Mascarenhas A, Jose Temido M, Morao B, et al
Early intervention with biologic therapy in Crohn s disease: how early is early?
J Crohns Colitis. 2023;17:1752-1760.
PubMed Abstract available

SCHULZE LL, Becker E, Dedden M, Liu LJ, et al
Differential Effects of Ontamalimab Versus Vedolizumab on Immune Cell Trafficking in Intestinal Inflammation and Inflammatory Bowel Disease.
J Crohns Colitis. 2023;17:1817-1832.
PubMed Abstract available

MEHTA S
Intestinal Failure: A Small but Imperfectly Phenotyped Complication of Crohn's Disease.
J Crohns Colitis. 2023 Nov 21:jjad154. doi: 10.1093.
PubMed

ROCHA CH, Walshe M, Birch S, Sabic K, et al
Clinical predictors of early and late endoscopic recurrence following ileocolonic resection in Crohn's disease.
J Crohns Colitis. 2023 Nov 17:jjad186. doi: 10.1093.
PubMed Abstract available

RONSIN C, Le Berre C, Ville S
Kidney injuries as Extra Intestinal Manifestation of Inflammatory Bowel Disease.
J Crohns Colitis. 2023 Nov 15:jjad191. doi: 10.1093.
PubMed

VERSTOCKT B, Vermeire S, Peyrin-Biroulet L, Mosig R, et al
The Safety, Tolerability, Pharmacokinetics and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b Study.
J Crohns Colitis. 2023 Nov 11:jjad192. doi: 10.1093.
PubMed Abstract available

SZEKELY H, Th LMT, Rancz A, Walter A, et al
Anti-tumor necrosis factor alpha versus corticosteroids: a threefold difference in the occurence of venous thromboembolism in Inflammatory Bowel Disease - a systematic review and meta-analysis.
J Crohns Colitis. 2023 Nov 11:jjad193. doi: 10.1093.
PubMed Abstract available

TANDON P, Huang VW, Feig DS, Saskin R, et al
Differences in Healthcare Utilization in Women with and without Inflammatory Bowel Diseases During Preconception, Pregnancy and Postpartum: A Population-Based Cohort Study.
J Crohns Colitis. 2023;17:1587-1595.
PubMed Abstract available

DRUVEFORS E, Myrelid P, Andersson RE, Landerholm K, et al
Female and Male Fertility after Colectomy and Reconstructive Surgery in Inflammatory Bowel Diesase: A National Cohort Study from Sweden.
J Crohns Colitis. 2023;17:1631-1638.
PubMed Abstract available

RAINE T, Ishiguro Y, Rubin DT, Finney-Hayward T, et al
Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: a Post Hoc Analysis of the Phase 3 Clinical Trial Programme.
J Crohns Colitis. 2023 Nov 6:jjad190. doi: 10.1093.
PubMed Abstract available

LIU Z, Alexander JL, Eng KY, Ibraheim H, et al
Antibody responses to Influenza vaccination are diminished in patients with inflammatory bowel disease on infliximab or tofacitinib.
J Crohns Colitis. 2023 Nov 6:jjad182. doi: 10.1093.
PubMed Abstract available

VERMEIRE S, Hanzel J, Lowenberg M, Ferrante M, et al
Early versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes.
J Crohns Colitis. 2023 Nov 2:jjad179. doi: 10.1093.
PubMed Abstract available

ROBLIN X, Nancey S, Papamichael K, Duru G, et al
Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease.
J Crohns Colitis. 2023 Nov 2:jjad188. doi: 10.1093.
PubMed Abstract available

VUYYURU SK, Solitano V, Narula N, Lee MJ, et al
Pharmacological therapies for the management of fistulising Crohn's disease: A systematic review and meta-analysis.
J Crohns Colitis. 2023 Nov 2:jjad185. doi: 10.1093.
PubMed Abstract available

GISBERT JP, Chaparro M
De-escalation of biological treatment in inflammatory bowel disease: A comprehensive review.
J Crohns Colitis. 2023 Nov 1:jjad181. doi: 10.1093.
PubMed Abstract available

CASAS DEZA D, Polo Cuadro C, de Francisco R, Vela Gonzalez M, et al
Initial management of intraabdominal abscesses and preventive strategies for abscess recurrence in penetrating Crohn's disease: a national multicenter study based on ENEIDA registry.
J Crohns Colitis. 2023 Nov 1:jjad184. doi: 10.1093.
PubMed Abstract available

October 2023

BOYD T, Araka EB, Kochar B, Ananthakrishnan AN, et al
Differences in Management and Outcomes of Older and Younger Adults with Acute Severe Ulcerative Colitis.
J Crohns Colitis. 2023 Oct 28:jjad183. doi: 10.1093.
PubMed Abstract available

COHEN NA, Weber CR, Cheng JX, Choi D, et al
Ozanimod-Exposed Patients with Ulcerative Colitis Undergoing Total Colectomy Exhibit Unique Lymph Node Histologic Changes.
J Crohns Colitis. 2023 Oct 25:jjad174. doi: 10.1093.
PubMed Abstract available

ASSCHER VER, Rodriguez Girondo MDM, Fens J, Waars SN, et al
Frailty screening associates with hospitalization and decline in quality of life and functional status in older patients with inflammatory bowel disease.
J Crohns Colitis. 2023 Oct 23:jjad175. doi: 10.1093.
PubMed Abstract available

MULLER M, Broseus J, Guilloteau A, Wasse S, et al
Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa.
J Crohns Colitis. 2023 Oct 18:jjad177. doi: 10.1093.
PubMed Abstract available

ALIBERT L, Betton L, Falcoz A, Manceau G, et al
Does KONO-S anastomosis reduce recurrence in Crohn's disease compared to conventional ileocolonic anastomosis? A nationwide propensity score-matched study from GETAID Chirurgie Group (KoCoRICCO study).
J Crohns Colitis. 2023 Oct 18:jjad176. doi: 10.1093.
PubMed Abstract available

ROBLIN X, Paul S
Adalimumab: A 'Maillon Faible' in the Treatment of Ulcerative Colitis?
J Crohns Colitis. 2023 Oct 17:jjad167. doi: 10.1093.
PubMed

RYMARCZYK D, Schultz W, Borowa A, Friedman JR, et al
Deep learning models capture histological disease activity in Crohn's Disease and Ulcerative Colitis with high fidelity.
J Crohns Colitis. 2023 Oct 10:jjad171. doi: 10.1093.
PubMed Abstract available

VERSTOCKT B, Pivorunas V, Mahi NA, Smaoui N, et al
Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies.
J Crohns Colitis. 2023 Oct 6:jjad170. doi: 10.1093.
PubMed Abstract available

FERRANTE M, Irving PM, Abreu MT, Axler J, et al
Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 Trial.
J Crohns Colitis. 2023 Oct 5:jjad168. doi: 10.1093.
PubMed Abstract available

September 2023

ATREYA R, Kuhbacher T, Waldner MJ, Hirschmann S, et al
Submucosal injection of the RNA oligonucleotide GUT-1 in active ulcerative colitis patients: A randomized, double-blind, placebo-controlled phase 2a induction trial.
J Crohns Colitis. 2023 Sep 30:jjad162. doi: 10.1093.
PubMed Abstract available

BAI BYH, Reppell M, Smaoui N, Waring JF, et al
Baseline expression of immune gene modules in blood is associated with primary response to anti-TNF therapy in Crohn's disease patients.
J Crohns Colitis. 2023 Sep 30:jjad166. doi: 10.1093.
PubMed Abstract available

BONAZ B, Sinniger V
Targeting the Vagus Nerve to Treat Inflammatory Bowel Disease?
J Crohns Colitis. 2023 Sep 21:jjad149. doi: 10.1093.
PubMed

D'HAENS G, Eberhardson M, Cabrijan Z, Danese S, et al
Neuroimmune modulation through vagus nerve stimulation reduces inflammatory activity in Crohn's disease patients: a prospective open label study.
J Crohns Colitis. 2023 Sep 21:jjad151. doi: 10.1093.
PubMed Abstract available

FOCHT G, Turner D
Lemman Index in pediatric Crohn's disease - evidence is accumulating.
J Crohns Colitis. 2023 Sep 14:jjad161. doi: 10.1093.
PubMed

JEW M, Meserve J, Eisenstein S, Jairath V, et al
Temporary Faecal Diversion for Refractory Perianal and/or Distal Colonic Crohn's Disease in the Biologic Era: An Updated Systematic Review with Meta-Analysis.
J Crohns Colitis. 2023 Sep 14:jjad159. doi: 10.1093.
PubMed Abstract available

VIOLA A, Li Voti R, Bivacqua C, de Francesco C, et al
Mitigating the risk of Tofacitinib-induced adverse events in the elderly population with Ulcerative Colitis.
J Crohns Colitis. 2023 Sep 13:jjad158. doi: 10.1093.
PubMed Abstract available

BEHESHTI MAAL A, Shahrbaf MA, Sadri B, Hossein-Khannazer N, et al
Prevalence of hepatobiliary manifestations in inflammatory bowel disease: a GRADE assessed systematic review and meta-analysis on more than 1.7 million patients.
J Crohns Colitis. 2023 Sep 11:jjad157. doi: 10.1093.
PubMed Abstract available

HARNIK S, Abitbol CM, Haj Natour O, Yavzori M, et al
Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II Study.
J Crohns Colitis. 2023 Sep 11:jjad156. doi: 10.1093.
PubMed Abstract available

NIELSEN KR, Midjord J, Lophaven SN, Langholz E, et al
The incidence and prevalence of inflammatory bowel disease continues to increase in the Faroe Islands - a cohort study from 1960-2020.
J Crohns Colitis. 2023 Sep 5:jjad155. doi: 10.1093.
PubMed Abstract available

SINGH A, Midha V, Kaur K, Mahajan R, et al
Tofacitinib versus oral prednisolone for induction of remission in moderately active ulcerative colitis (ORCHID): A prospective, open-label, randomized, pilot study.
J Crohns Colitis. 2023 Sep 1:jjad153. doi: 10.1093.
PubMed Abstract available

August 2023

DANESE S, Panaccione R, Abreu MT, Rubin DT, et al
Efficacy and safety of approximately 3 years of continuous ozanimod in moderately to severely active ulcerative colitis: interim analysis of the True North open-label extension.
J Crohns Colitis. 2023 Aug 31:jjad146. doi: 10.1093.
PubMed Abstract available

TRINH S, Andrew B, Vasudevan A
6-mercaptopurine in ulcerative colitis: the potential of upfront dosing with allopurinol.
J Crohns Colitis. 2023 Aug 29:jjad150. doi: 10.1093.
PubMed

PIAZZA O SED N, Noviello D, Filippi E, Conforti F, et al
Superior predictive value of transmural over endoscopic severity for colectomy risk in ulcerative colitis: a multicenter prospective cohort study.
J Crohns Colitis. 2023 Aug 26:jjad152. doi: 10.1093.
PubMed Abstract available

MILO F, Imondi C, D'Amore C, Angelino G, et al
Short Term Psychodynamic Psychotherapy in addition to standard medical therapy increases clinical remission in Adolescents and Young Adults with Inflammatory Bowel Disease: a randomised controlled trial.
J Crohns Colitis. 2023 Aug 24:jjad145. doi: 10.1093.
PubMed Abstract available

REINISCH W, Pradhan V, Ahmad S, Zhang Z, et al
Alternative endoscopy reading paradigms determine score reliability and effect size in ulcerative colitis.
J Crohns Colitis. 2023 Aug 24:jjad134. doi: 10.1093.
PubMed Abstract available

FEAKINS R, Borralho Nunes P, Driessen A, Gordon IO, et al
Definitions of histological abnormalities in inflammatory bowel disease: an ECCO position paper.
J Crohns Colitis. 2023 Aug 22:jjad142. doi: 10.1093.
PubMed Abstract available

WEWER MD, Jansson S, Malham M, Burisch J, et al
Disease Activity Patterns of Paediatric Inflammatory Bowel Disease - A Danish Nationwide Cohort Study (1996-2018).
J Crohns Colitis. 2023 Aug 21:jjad144. doi: 10.1093.
PubMed Abstract available

QIAN W, Xu Y, Wen W, Huang L, et al
Exosomal miR-103a-3p from Crohn's Creeping Fat-Derived Adipose-Derived Stem Cells Contributes to Intestinal Fibrosis by Targeting TGFBR3 and Activating Fibroblasts.
J Crohns Colitis. 2023;17:1291-1308.
PubMed Abstract available

HU X, Jiao F, Deng J, Zhou Z, et al
Intestinal Epithelial Cell-specific Deletion of Cytokine-inducible SH2-containing Protein Alleviates Experimental Colitis in Ageing Mice.
J Crohns Colitis. 2023;17:1278-1290.
PubMed Abstract available

GORDON H, Rodger B, Lindsay JO, Stagg AJ, et al
Recruitment and Residence of Intestinal T Cells - Lessons for Therapy in Inflammatory Bowel Disease.
J Crohns Colitis. 2023;17:1326-1341.
PubMed Abstract available

WRIGHT EK, Chaparro M, Gionchetti P, Hamilton AL, et al
Adalimumab Clearance, rather than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically.
J Crohns Colitis. 2023 Aug 18:jjad140. doi: 10.1093.
PubMed Abstract available

KIM K, Park S, Lee Y, Baek J, et al
Transcriptomic Profiling and Cellular Composition of Creeping Fat in Crohn's disease.
J Crohns Colitis. 2023 Aug 18:jjad141. doi: 10.1093.
PubMed Abstract available

Corrigendum to: Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial.
J Crohns Colitis. 2023 Aug 17:jjad136. doi: 10.1093.
PubMed

PELTON M, Ssentongo P, Sun A, Groff D, et al
Race & Ethnic Representation in Crohn's Disease Trials of Biologic and Small Molecule Medications: A Systematic Review and Meta-Analysis.
J Crohns Colitis. 2023 Aug 16:jjad138. doi: 10.1093.
PubMed Abstract available

SCHREIBER S, Danese S, Dignass A, Domenech E, et al
Defining Comprehensive Disease Control for use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus Recommendations.
J Crohns Colitis. 2023 Aug 16:jjad130. doi: 10.1093.
PubMed Abstract available

RANJAN MK, Kumar P, Kumar Vuyyuru S, Kante B, et al
Thiopurines have sustained long-term effectiveness in patients with inflammatory bowel disease which is independent of disease duration at initiation: A propensity score matched analysis.
J Crohns Colitis. 2023 Aug 16:jjad135. doi: 10.1093.
PubMed Abstract available

WIESE JJ, Manna S, Kuhl AA, Fasci A, et al
Myenteric plexus immune cell infiltrations and neurotransmitter expression in Crohn's disease and ulcerative colitis.
J Crohns Colitis. 2023 Aug 11:jjad122. doi: 10.1093.
PubMed Abstract available

LIN S, Hannon E, Reppell M, Waring JF, et al
Whole blood DNA methylation changes are associated with anti-TNF drug concentration in patients with Crohn's disease.
J Crohns Colitis. 2023 Aug 8:jjad133. doi: 10.1093.
PubMed Abstract available

VERMEIRE S, Feagan BG, Peyrin-Biroulet L, Oortwijn A, et al
Withdrawal and Re-treatment with Filgotinib in Ulcerative Colitis: Post Hoc Analyses of the Phase 2b/3 SELECTION and SELECTIONLTE Studies.
J Crohns Colitis. 2023 Aug 4:jjad123. doi: 10.1093.
PubMed Abstract available

KRISHNAMOORTHY A, Chandrapalan S, Ahmed M, Arasaradnam RP, et al
The Diagnostic Utility of Volatile Organic Compounds in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
J Crohns Colitis. 2023 Aug 4:jjad132. doi: 10.1093.
PubMed Abstract available

HURYCH J, Mascellani Bergo A, Lerchova T, Hlinakova L, et al
Faecal bacteriome and metabolome profiles associated with decreased mucosal inflammatory activity upon anti-TNF therapy in paediatric Crohn's disease.
J Crohns Colitis. 2023 Aug 1:jjad126. doi: 10.1093.
PubMed Abstract available

BRODERSEN JB, Jensen MD, Leenhardt R, Kjeldsen J, et al
Artificial intelligence-assisted analysis of pan-enteric capsule endoscopy in patients with suspected Crohn's disease. A study on diagnostic performance.
J Crohns Colitis. 2023 Aug 1:jjad131. doi: 10.1093.
PubMed Abstract available

JOUSTRA V, Li Yim AYF, van Gennep S, Hageman I, et al
Peripheral blood DNA methylation signatures and response to tofacitinib in moderate-to-severe ulcerative colitis.
J Crohns Colitis. 2023 Aug 1:jjad129. doi: 10.1093.
PubMed Abstract available

GUADAGNOLI L, Horrigan J, Walentynowicz M, Salwen-Deremer JK, et al
Sleep quality drives next day pain and fatigue in adults with inflammatory bowel disease: A short report.
J Crohns Colitis. 2023 Aug 1:jjad128. doi: 10.1093.
PubMed Abstract available

July 2023

KIM K, Oh SJ, Lee J, Kwon A, et al
Regulatory Variants on the Leukocyte Immunoglobulin-Like Receptor Gene Cluster are Associated with Crohn's Disease and Interact with Regulatory Variants for TAP2.
J Crohns Colitis. 2023 Jul 31:jjad127. doi: 10.1093.
PubMed Abstract available

CARON B, Jairath V, Laurent V, Stoker J, et al
Defining magnetic resonance imaging treatment response and remission in Crohn's disease: a systematic review.
J Crohns Colitis. 2023 Jul 31:jjad125. doi: 10.1093.
PubMed Abstract available

GARCIA MJ, Rivero M, Fernandez-Clotet A, de Francisco R, et al
Comparative Study Of The Effectiveness Of Vedolizumab Versus Ustekinumab After Anti-Tnf Failure In Crohn's Disease (Versus-Cd): Data From Eneida Registry.
J Crohns Colitis. 2023 Jul 31:jjad124. doi: 10.1093.
PubMed Abstract available

UNGARO RC, Kadali H, Zhang W, Adsul S, et al
Impact of Concomitant 5-Aminosalicylic Acid Therapy on Vedolizumab Efficacy and Safety in Inflammatory Bowel Disease: Post Hoc Analyses of Clinical Trial Data.
J Crohns Colitis. 2023 Jul 26:jjad113. doi: 10.1093.
PubMed Abstract available

ATIA O, Friss C, Focht G, Magen Rimon R, et al
Durability of the first biologic in patients with Crohn's disease: A nationwide study from the epi-IIRN.
J Crohns Colitis. 2023 Jul 19:jjad121. doi: 10.1093.
PubMed Abstract available

PARONI M, Leccese G, Ranzani V, Moschetti G, et al
An intestinal Th17 subset is associated with inflammation in Crohn's Disease and activated by adherent-invasive Escherichia coli (AIEC).
J Crohns Colitis. 2023 Jul 18:jjad119. doi: 10.1093.
PubMed Abstract available

UEDA T, Koyama F, Sugita A, Ikeuchi H, et al
Endoscopic lesions of postoperative anastomotic area in patients with Crohn's disease in the biologic era: A Japanese multi-center nationwide cohort study.
J Crohns Colitis. 2023 Jul 14:jjad116. doi: 10.1093.
PubMed Abstract available

HUININK STB, Thomassen D, Steyerberg EW, Pauwels RWM, et al
Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn's Disease: Individual Participant Data Meta-Analysis of 309 patients from 12 studies.
J Crohns Colitis. 2023 Jul 12:jjad118. doi: 10.1093.
PubMed Abstract available

SANDS BE, Schreiber S, Blumenstein I, Chiorean MV, et al
Clinician's Guide to Using Ozanimod for the Treatment of Ulcerative Colitis.
J Crohns Colitis. 2023 Jul 12:jjad112. doi: 10.1093.
PubMed Abstract available

GONCZI L, Lakatos L, Golovics PA, Ilias A, et al
Declining trends of reoperations and disease behavior progression in Crohn's disease over different therapeutic eras - a prospective population-based study from western Hungary between 1977-2020, data from the Veszprem cohort.
J Crohns Colitis. 2023 Jul 9:jjad117. doi: 10.1093.
PubMed Abstract available

GILMORE R, Tan L, Fernandes R, An YK, et al
Upadacitinib Salvage Therapy for Infliximab experienced patients with Acute Severe Ulcerative Colitis.
J Crohns Colitis. 2023 Jul 9:jjad115. doi: 10.1093.
PubMed Abstract available

BRYANT RV, Travis SPL
APOLLO Has Landed: PROMS and Histology in UC.
J Crohns Colitis. 2023;17:1027-1028.
PubMed

UZZAN M, Bouhnik Y, Abreu M, Ahmad HA, et al
Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions.
J Crohns Colitis. 2023;17:1066-1078.
PubMed Abstract available

LEDDER O, Turner D
Multi-item Measures for Paediatric Inflammatory Bowel Diseases: The ABCs of All Those Acronyms.
J Crohns Colitis. 2023;17:1154-1168.
PubMed Abstract available

GRIMSDOTTIR S, Attauabi M, Kristine Dahl E, Burisch J, et al
Systematic Review with Meta-analysis: The Impact of Cancer Treatments on the Disease Activity of Inflammatory Bowel Diseases.
J Crohns Colitis. 2023;17:1139-1153.
PubMed Abstract available

ALEXANDERSSON BT, Andreasson A, Hedin C, Broms G, et al
Inflammatory bowel disease is not linked to a higher rate of adverse events in colonoscopy - a nationwide population-based study in Sweden.
J Crohns Colitis. 2023 Jul 4:jjad114. doi: 10.1093.
PubMed Abstract available

SCHREIBER S, Rubin DT, Ng SC, Peyrin-Biroulet L, et al
Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme.
J Crohns Colitis. 2023 Jul 4:jjad104. doi: 10.1093.
PubMed Abstract available

June 2023

PARIGI TL, Cannatelli R, Nardone OM, Zammarchi I, et al
Neutrophil-only histological assessment of ulcerative colitis correlates with endoscopic activity and predicts long-term outcomes in a multicenter study.
J Crohns Colitis. 2023 Jun 30:jjad110. doi: 10.1093.
PubMed Abstract available

SEETHARAMAN J, Srivastava A, Yadav RR, Singh SK, et al
Visceral fat indices: Do they help differentiate Crohn's disease and Intestinal tuberculosis in children?
J Crohns Colitis. 2023 Jun 30:jjad109. doi: 10.1093.
PubMed Abstract available

GORDON H, Burisch J, Ellul P, Karmiris K, et al
ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease.
J Crohns Colitis. 2023 Jun 23:jjad108. doi: 10.1093.
PubMed

FENG R, Tian Z, Mao R, Ma R, et al
Gut microbiome generated phenylacetylglutamine from dietary protein is associated with Crohn's Disease and exacerbates colitis in mouse model possibly via platelet activation.
J Crohns Colitis. 2023 Jun 23:jjad098. doi: 10.1093.
PubMed Abstract available

MATHEWS SN, Lukin DJ
Shifting the Inflammatory Balance in Ulcerative Colitis Through Diet: A Mediterranean Diet Pattern is Associated with Improvements in Dysbiosis and Disease Activity.
J Crohns Colitis. 2023 Jun 23:jjad095. doi: 10.1093.
PubMed

YU N, Sriranganathan D, Walker GJ, Sazonovs A, et al
Prevalence of NUDT15 genetic variants and incidence of thiopurine-induced leukopenia in Inflammatory Bowel Disease: A systematic review and meta-analysis.
J Crohns Colitis. 2023 Jun 22:jjad107. doi: 10.1093.
PubMed Abstract available

BURISCH J, Safroneeva E, Laoun R, Ma C, et al
Lack of benefit for early escalation to advanced therapies in ulcerative colitis: critical appraisal of current evidence.
J Crohns Colitis. 2023 Jun 22:jjad106. doi: 10.1093.
PubMed Abstract available

KOPCZYNSKA M, Crooks B, Deutsch L, Conley T, et al
Disease recurrence and long-term outcomes following the development of intestinal failure in Crohn's disease: over 20 years of experience from a national reference centre.
J Crohns Colitis. 2023 Jun 21:jjad105. doi: 10.1093.
PubMed Abstract available

FOCHT G, Kuint RC, Greer MC, Pratt LT, et al
Prospective Validation of the Lemann Index in Children: A Report From the Multicentre Image Kids Study.
J Crohns Colitis. 2023;17:943-949.
PubMed Abstract available

KANTASIRIPITAK W, Wicha SG, Thomas D, Hoffman I, et al
A Model-Based Tool for Guiding Infliximab Induction Dosing to Maximize Long-term Deep Remission in Children with Inflammatory Bowel Diseases.
J Crohns Colitis. 2023;17:896-908.
PubMed Abstract available

GISBERT JP, Chaparro M
Vaccines in Children Exposed to Biological Agents In Utero and/or During Breastfeeding: Are They Effective and Safe?
J Crohns Colitis. 2023;17:995-1009.
PubMed Abstract available

WEBER MC, Bauer J, Buck A, Clees Z, et al
Perioperative Low-Dose Prednisolone Treatment Has Beneficial Effects on Postoperative Recovery and Anastomotic Healing in a Murine Colitis Model.
J Crohns Colitis. 2023;17:950-959.
PubMed Abstract available

SOLITANO V, Vuyyuru SK, MacDonald JK, Zayadi A, et al
Efficacy and safety of advanced oral small molecules for inflammatory bowel disease: Systematic review and meta-analysis.
J Crohns Colitis. 2023 Jun 15:jjad100. doi: 10.1093.
PubMed Abstract available

JANSEN FM, van Linschoten RCA, Kievit W, Smits LJT, et al
Cost-effectiveness analysis of increased adalimumab dose intervals in Crohn's disease patients in stable remission: the randomised controlled LADI trial.
J Crohns Colitis. 2023 Jun 13:jjad101. doi: 10.1093.
PubMed Abstract available

MATINI L, Chapman TP, Kantschuster R, Wilson J, et al
Development of the Escalation of Therapy or Intervention (ETI) calculator for patients with ulcerative colitis using ePROMS.
J Crohns Colitis. 2023 Jun 12:jjad099. doi: 10.1093.
PubMed Abstract available

EDER P, Verstock B, Culver E, Dragoni G, et al
Autoimmune pancreatitis in patients with inflammatory bowel disease - a real-world multicentre collaborative ECCO CONFER study.
J Crohns Colitis. 2023 Jun 7:jjad097. doi: 10.1093.
PubMed Abstract available

SUN Z, Braga-Neto MB, Xiong Y, Bhagwate AV, et al
Hypomethylation and overexpression of Th17-associated genes is a hallmark of intestinal CD4+ lymphocytes in Crohn's disease.
J Crohns Colitis. 2023 Jun 6:jjad093. doi: 10.1093.
PubMed Abstract available

SABINO J, Tarassishin L, Eisele C, Hawkins K, et al
Influence of Early Life Factors, including Breastmilk Composition, on the Microbiome of Infants Born to Mothers with and without Inflammatory Bowel Disease.
J Crohns Colitis. 2023 Jun 6:jjad096. doi: 10.1093.
PubMed Abstract available

HOLTEN KA, Bernklev T, Opheim R, Johansen I, et al
Fatigue in patients with newly diagnosed inflammatory bowel disease: Results from a prospective inception cohort, the IBSEN III study.
J Crohns Colitis. 2023 Jun 5:jjad094. doi: 10.1093.
PubMed Abstract available

May 2023

BRUGGELING CE, Te Groen M, Garza DR, van Heeckeren Tot Overlaer F, et al
Bacterial oncotraits rather than spatial organization are associated with dysplasia in ulcerative colitis.
J Crohns Colitis. 2023 May 27:jjad092. doi: 10.1093.
PubMed Abstract available

MOTWANI KK, Hashash JG, Farraye FA, Kappelman MD, et al
Impact of Holding Immunosuppressive Therapy in Patients with Inflammatory Bowel Disease Around mRNA COVID-19 Vaccine Administration on Humoral Immune Response and Development of COVID-19 Infection.
J Crohns Colitis. 2023 May 26:jjad085. doi: 10.1093.
PubMed Abstract available

Correction to: Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study.
J Crohns Colitis. 2023 May 24:jjad082. doi: 10.1093.
PubMed

PEYRIN-BIROULET L, Arenson E, Rubin DT, Siegel CA, et al
A comparative evaluation of the measurement properties of three histological indices of mucosal healing in ulcerative colitis: Geboes Score, Robarts Histopathology Index, and Nancy Index.
J Crohns Colitis. 2023 May 24:jjad087. doi: 10.1093.
PubMed Abstract available

HONAP S, Buisson A, Danese S, Laurent B, et al
Patient and Public Involvement in Research: Lessons for Inflammatory Bowel Disease.
J Crohns Colitis. 2023 May 23:jjad090. doi: 10.1093.
PubMed Abstract available

PIERRE N, Vieujean S, Peyrin-Biroulet L, Meuwis MA, et al
Defining biological remission in Crohn's disease: interest, challenges and future directions.
J Crohns Colitis. 2023 May 19:jjad086. doi: 10.1093.
PubMed Abstract available

STAFFORD IS, Ashton JJ, Mossotto E, Cheng G, et al
Supervised machine learning classifies inflammatory bowel disease patients by subtype using whole exome sequencing data.
J Crohns Colitis. 2023 May 19:jjad084. doi: 10.1093.
PubMed Abstract available

KABIR M, Thomas-Gibson S, Tozer PJ, Warusavitarne J, et al
DECIDE: Delphi Expert Consensus Statement on Inflammatory Bowel Disease Dysplasia Shared Management Decision-Making.
J Crohns Colitis. 2023 May 12:jjad083. doi: 10.1093.
PubMed Abstract available

ITZKOWITZ S, Farraye FA, Limburg P, Gagrat Z, et al
Assessment of Stool DNA Markers to Detect Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: A Multi-site Case-control Study.
J Crohns Colitis. 2023 May 11:jjad069. doi: 10.1093.
PubMed Abstract available

OHLMANN H, Lanters LR, Theysohn N, Langhorst J, et al
Distinct alterations in central pain processing of visceral and somatic pain in quiescent ulcerative colitis compared to irritable bowel syndrome and health.
J Crohns Colitis. 2023 May 10:jjad080. doi: 10.1093.
PubMed Abstract available

IRVING PM
Thiopurines for Ulcerative Colitis: Old Favourite or Old Hat?
J Crohns Colitis. 2023 May 4:jjad062. doi: 10.1093.
PubMed

BAI L, Dermadi D, Kalesinskas L, Dvorak M, et al
Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD.
J Crohns Colitis. 2023;17:804-815.
PubMed Abstract available

GODNY L, Svolos V, Williams AJ, Czuber-Dochan W, et al
Multidisciplinary Perinatal Care in IBD.
J Crohns Colitis. 2023;17:663-680.
PubMed Abstract available

VERMEIRE S, Solitano V, Peyrin-Biroulet L, Tilg H, et al
Obefazimod: A First-in-class Drug for the Treatment of Ulcerative Colitis.
J Crohns Colitis. 2023 May 2:jjad067. doi: 10.1093.
PubMed Abstract available

April 2023

MCCURDY JD, Weng R, Parlow S, Dawkins YM, et al
Video capsule endoscopy can identify occult luminal Crohn's disease in patients with isolated perianal fistulas.
J Crohns Colitis. 2023 Apr 26:jjad078. doi: 10.1093.
PubMed Abstract available

ATIA O, Friss C, Ledderman N, Greenfeld S, et al
Thiopurines have longer treatment durability than methotrexate in adults and children with Crohn's Disease: a nationwide analysis from the epi-IIRN cohort.
J Crohns Colitis. 2023 Apr 26:jjad076. doi: 10.1093.
PubMed Abstract available

KURIAKOSE KUZHIYANJAL AJ, Nigam GB, Antoniou GA, Farraye FA, et al
Management of Inflammatory Bowel Disease Using E-Health Technologies: A Systematic Review and Meta-Analysis.
J Crohns Colitis. 2023 Apr 26:jjad075. doi: 10.1093.
PubMed Abstract available

TSCHURTSCHENTHALER M, Verstockt B
Targeting a Hallmark of Crohn's Disease: Browning of the Hypertrophic Mesenteric Adipose Tissue as a Novel Strategy to Reduce Inflammation?
J Crohns Colitis. 2023 Apr 26:jjad059. doi: 10.1093.
PubMed

ALSOUD D, Ho J, Verstockt B
The Serum-Based Endoscopic Healing Index Can Monitor Therapeutic Response in Crohn's Disease.
J Crohns Colitis. 2023 Apr 26:jjad077. doi: 10.1093.
PubMed

HASKEY N, Estaki M, Ye J, Shim RK, et al
A Mediterranean Diet Pattern improves intestinal inflammation concomitant with reshaping of the bacteriome in ulcerative colitis: A randomized controlled trial.
J Crohns Colitis. 2023 Apr 24:jjad073. doi: 10.1093.
PubMed Abstract available

LAURI G, D'Amico F, Allocca M, Palumbo D, et al
Ustekinumab as induction and maintenance therapy in patients with inflammatory bowel disease and type II autoimmune pancreatitis: report of two cases.
J Crohns Colitis. 2023 Apr 22:jjad072. doi: 10.1093.
PubMed

ALLOCCA M, Dell'Avalle C, Furfaro F, Zilli A, et al
Early intestinal ultrasound predicts long-term endoscopic response to biologics in ulcerative colitis.
J Crohns Colitis. 2023 Apr 21:jjad071. doi: 10.1093.
PubMed Abstract available

GORELIK Y, Ghersin I, Shlon D, Friss C, et al
Association of Antibiotic Use with Durability of Biologic Agents in Inflammatory Bowel Disease: a report from the epi-IIRN.
J Crohns Colitis. 2023 Apr 21:jjad070. doi: 10.1093.
PubMed Abstract available

LIGHTNER AL, Reese J, Ream J, Nachand D, et al
A Phase IB/IIA Study of Allogeneic, Bone Marrow-derived, Mesenchymal Stem Cells for the Treatment of Refractory Ileal-anal Anastomosis and Peripouch Fistulas in the Setting of Crohn's Disease of the Pouch.
J Crohns Colitis. 2023;17:480-488.
PubMed Abstract available

CAO D, Qian K, Zhao Y, Hong J, et al
Association of Neutrophil Extracellular Traps with Fistula Healing in Patients with Complex Perianal Fistulizing Crohn's Disease.
J Crohns Colitis. 2023;17:580-592.
PubMed Abstract available

VIEUJEAN S, De Vos M, Paridaens K, Daftary GS, et al
Fertility and Assisted Reproductive Technologies Outcomes of Women with Non-surgically Managed Inflammatory Bowel Diseases: A Systematic Review.
J Crohns Colitis. 2023;17:614-632.
PubMed Abstract available

NIGHOT M, Liao PL, Morris N, McCarthy D, et al
Long-Term Use of Proton Pump Inhibitors Disrupts Intestinal Tight Junction Barrier and Exaggerates Experimental Colitis.
J Crohns Colitis. 2023;17:565-579.
PubMed Abstract available

CHEN J, Wellens J, Kalla R, Fu T, et al
Intake of Ultra-processed Foods Is Associated with an Increased Risk of Crohn's Disease: A Cross-sectional and Prospective Analysis of 187 154 Participants in the UK Biobank.
J Crohns Colitis. 2023;17:535-552.
PubMed Abstract available

CHUGH R, Braga-Neto MB, Fredrick TW, Ramos GP, et al
Multicentre Real-world Experience of Upadacitinib in the Treatment of Crohn's Disease.
J Crohns Colitis. 2023;17:504-512.
PubMed Abstract available

SHARMA T, Ma C, Sedano R, Hanzel J, et al
Placebo Response Rates in Randomized Controlled Trials for Perianal Crohn's Disease: A Systematic Review and Meta-Analysis.
J Crohns Colitis. 2023;17:644-658.
PubMed Abstract available

ELMAGHRAWY K, Fleming P, Fitzgerald K, Cooper S, et al
The Oral Microbiome in Treatment-Naive Paediatric IBD Patients Exhibits Dysbiosis Related to Disease Severity that Resolves Following Therapy.
J Crohns Colitis. 2023;17:553-564.
PubMed Abstract available

ZHAO J, Lin Z, Ying P, Zhao Z, et al
circSMAD4 Promotes Experimental Colitis and Impairs Intestinal Barrier Functions by Targeting Janus Kinase 2 Through Sponging miR-135a-5p.
J Crohns Colitis. 2023;17:593-613.
PubMed Abstract available

DRAGONI G, Allocca M, Myrelid P, Noor NM, et al
Results of the Eighth Scientific Workshop of ECCO: Diagnosing postoperative recurrence of Crohn's disease after an ileocolonic resection with ileocolonic anastomosis.
J Crohns Colitis. 2023 Apr 18:jjad055. doi: 10.1093.
PubMed Abstract available

RIVIERE P, Bislenghi G, Hammoudi N, Verstockt B, et al
Results of the Eighth Scientific Workshop of ECCO: Pathophysiology and risk factors of postoperative Crohn's disease recurrence after an ileocolic resection.
J Crohns Colitis. 2023 Apr 18:jjad054. doi: 10.1093.
PubMed Abstract available

FERRANTE M, Pouillon L, Manosa M, Savarino E, et al
Results of the Eighth Scientific Workshop of ECCO: Prevention and treatment of postoperative recurrence in patients with Crohn's disease undergoing an ileocolonic resection with ileocolonic anastomosis.
J Crohns Colitis. 2023 Apr 18:jjad053. doi: 10.1093.
PubMed Abstract available

YAZAKI T, Kawashima K, Ishihara S
Azathioprine-induced porto-sinusoidal vascular disease complicated with esophageal varices in Crohn's disease patient - Case report.
J Crohns Colitis. 2023 Apr 17:jjad066. doi: 10.1093.
PubMed

Erratum to: Anogenital Crohn's Disease and Granulomatosis: A Systematic Review of Epidemiology, Clinical Manifestations, and Treatment.
J Crohns Colitis. 2023 Apr 15:jjad044. doi: 10.1093.
PubMed

MAGRO F, Pai RK, Kobayashi T, Jairath V, et al
Resolving Histologic Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial Programs.
J Crohns Colitis. 2023 Apr 14:jjad050. doi: 10.1093.
PubMed Abstract available

JANSEN D, Falony G, Vieira-Silva S, Simsek C, et al
Community Types Of The Human Gut Virome Are Associated With Endoscopic Outcome In Ulcerative Colitis.
J Crohns Colitis. 2023 Apr 13:jjad061. doi: 10.1093.
PubMed Abstract available

DRAGONI G, Gottin M, Innocenti T, Lynch EN, et al
"Correlation of ultrasound scores with endoscopic activity in Crohn's disease: a prospective exploratory study".
J Crohns Colitis. 2023 Apr 6:jjad068. doi: 10.1093.
PubMed Abstract available

DOHERTY J, O Morain N, Stack R, Tosetto M, et al
Reduced serological response to COVID-19 booster vaccine is associated with reduced B cell memory in patients with Inflammatory Bowel Disease; VARIATION (VAriability in Response in IBD AgainsT SARS-COV-2 ImmunisatiON).
J Crohns Colitis. 2023 Apr 5:jjad065. doi: 10.1093.
PubMed Abstract available

FURUKAWA S, Mizushima T, Nakaya R, Shibata M, et al
Darvadstrocel for Complex Perianal Fistulas in Japanese Adults with Crohn's Disease: A Phase 3 Study.
J Crohns Colitis. 2023;17:369-378.
PubMed Abstract available

JOHANSEN MP, Wewer MD, Nordholm-Carstensen A, Burisch J, et al
Perianal Crohn's Disease and the Development of Colorectal and Anal Cancer: A Systematic Review and Meta-analysis.
J Crohns Colitis. 2023;17:361-368.
PubMed Abstract available

JOUSTRA V, van Sabben J, van der Does de Willebois E, Duijvestein M, et al
Benefit of Risk-stratified Prophylactic Treatment on Clinical Outcome in Postoperative Crohn's Disease.
J Crohns Colitis. 2023;17:318-328.
PubMed Abstract available

WONG ECL, Moayyedi P, Narula N
Beyond the White Pill: Advocating for Racial Diversity in IBD Trials.
J Crohns Colitis. 2023;17:459-461.
PubMed Abstract available

ASHTON JJ, Seaby EG, Beattie RM, Ennis S, et al
NOD2 in Crohn's Disease-Unfinished Business.
J Crohns Colitis. 2023;17:450-458.
PubMed Abstract available

March 2023

AXELRAD J, Olen O, Soderling J, Roelstraete B, et al
Inflammatory Bowel Disease and Risk of Colorectal Polyps: A nationwide population-based cohort study from Sweden.
J Crohns Colitis. 2023 Mar 30:jjad056. doi: 10.1093.
PubMed Abstract available

CHEN LA, Oliva-Hemker M, Radin A, Weidner M, et al
Longitudinal bile acid composition changes following fecal microbiota transplantation for Clostridioides difficile infection in children with and without underlying inflammatory bowel disease.
J Crohns Colitis. 2023 Mar 29:jjad057. doi: 10.1093.
PubMed Abstract available

JANKER L, Schuster D, Bortel P, Hagn G, et al
Multi-omics empowered deep phenotyping of ulcerative colitis identifies biomarker signatures reporting functional remission states.
J Crohns Colitis. 2023 Mar 24:jjad052. doi: 10.1093.
PubMed Abstract available

FADEL MG, Geropoulos G, Warren OJ, Mills SC, et al
Risks factors associated with the development of Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis: a systematic review and meta-analysis.
J Crohns Colitis. 2023 Mar 24:jjad051. doi: 10.1093.
PubMed Abstract available

DE CODES LMG, de Jesus ACC, de Codes JJG, Ferreira RF, et al
Anorectal function and clinical characteristics associated with fecal incontinence in patients with Crohn's disease.
J Crohns Colitis. 2023 Mar 23:jjad048. doi: 10.1093.
PubMed Abstract available

ALLEZ M, Sands BE, Feagan BG, D'Haens G, et al
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients With Moderately to Severely Active Crohn's Disease.
J Crohns Colitis. 2023 Mar 20:jjad047. doi: 10.1093.
PubMed Abstract available

RUNDE J, Veseli I, Fogarty EC, Watson AR, et al
Transient Suppression of Bacterial Populations Associated with Gut Health is Critical in Success of Exclusive Enteral Nutrition for Children with Crohn's Disease.
J Crohns Colitis. 2023 Mar 19:jjad031. doi: 10.1093.
PubMed Abstract available

JONGSMA MME, Costes LMM, Tindemans I, Cozijnsen MA, et al
Serum immune profiling in pediatric Crohn's disease demonstrates stronger immune modulation with first-line infliximab than conventional therapy and pre-treatment profiles predict clinical response to both treatments.
J Crohns Colitis. 2023 Mar 19:jjad049. doi: 10.1093.
PubMed Abstract available

ZUO L, Geng Z, Song X, Li J, et al
Browning of mesenteric white adipose tissue in Crohn's disease: a new pathological change and therapeutic target.
J Crohns Colitis. 2023 Mar 18:jjad046. doi: 10.1093.
PubMed Abstract available

ROSS ADB, Zilbauer M
Validation of IBD-associated Whole-blood DNA Methylation Changes-Where Do We Go From Here?
J Crohns Colitis. 2023;17:151-152.
PubMed

HARVEY PR, Trudgill NJ
Venous Thromboembolism Following Discharge from Hospital in Patients Admitted for Inflammatory Bowel Diseases-Authors' Reply.
J Crohns Colitis. 2023;17:306.
PubMed

RIVIERE P, Pekow J, Hammoudi N, Wils P, et al
Comparison of the Risk of Crohn's Disease Postoperative Recurrence Between Modified Rutgeerts Score i2a and i2b Categories: An Individual Patient Data Meta-analysis.
J Crohns Colitis. 2023;17:269-276.
PubMed Abstract available

ARKENBOSCH JHC, Beelen EMJ, Dijkstra G, Romberg-Camps M, et al
Prophylactic Medication for the Prevention of Endoscopic Recurrence in Crohn's Disease: a Prospective Study Based on Clinical Risk Stratification.
J Crohns Colitis. 2023;17:221-230.
PubMed Abstract available

GONCZI L, Lakatos L, Kurti Z, Golovics PA, et al
Incidence, Prevalence, Disease Course, and Treatment Strategy of Crohn's Disease Patients from the Veszprem Cohort, Western Hungary: A Population-based Inception Cohort Study Between 2007 and 2018.
J Crohns Colitis. 2023;17:240-248.
PubMed Abstract available

SEBASTIAN S, Segal JP, Hedin C, Pellino G, et al
ECCO Topical Review: Roadmap to Optimal Peri-Operative Care in IBD.
J Crohns Colitis. 2023;17:153-169.
PubMed Abstract available

DAI C, Huang YH
Venous Thromboembolism Following Discharge from Hospital Among Patients Admitted for Inflammatory Bowel Diseases.
J Crohns Colitis. 2023;17:305.
PubMed

LIANG ZX, Liu HS, Xiong L, Zeng ZW, et al
GAS6 From CD200+ Adipose-Derived Stem Cells Mitigates Colonic Inflammation in a Macrophage-Dependent Manner.
J Crohns Colitis. 2023;17:289-301.
PubMed Abstract available

ALBUQUERQUE A, Cappello C, Stirrup O, Selinger CP, et al
Anal high-risk human papillomavirus infection, squamous intraepithelial lesions and anal cancer in patients with inflammatory bowel disease: a systematic review and meta-analysis.
J Crohns Colitis. 2023 Mar 17:jjad045. doi: 10.1093.
PubMed Abstract available

DOTAN I, Feagan BG, Taliadouros V, Oortwijn A, et al
Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial.
J Crohns Colitis. 2023 Mar 16:jjad039. doi: 10.1093.
PubMed Abstract available

JIMBO K, Hosoi K, Suzuki M, Kyodo R, et al
Accuracy of Transperineal Ultrasonography for Assessing Rectal Lesions in Pediatric Ulcerative Colitis: A Prospective Study.
J Crohns Colitis. 2023 Mar 15:jjad035. doi: 10.1093.
PubMed Abstract available

MACALUSO FS, Ventimiglia M, Orlando A
Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies.
J Crohns Colitis. 2023 Mar 13:jjad043. doi: 10.1093.
PubMed Abstract available

JANSSEN LM, Creemers RH, van Bodegraven AA, Pierik MJ, et al
A systematic review on long-term efficacy outcome measures in Crohn's disease patients.
J Crohns Colitis. 2023 Mar 13:jjad037. doi: 10.1093.
PubMed Abstract available

Erratum to: Post-inflammatory Polyp Burden as a Prognostic Marker of Disease-outcome in Patients with Inflammatory Bowel Disease.
J Crohns Colitis. 2023 Mar 9:jjad028. doi: 10.1093.
PubMed

YAMAMOTO T, Nakase H, Watanabe K, Shinzaki S, et al
Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn's Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn's Disease (iCREST-CD).
J Crohns Colitis. 2023 Mar 4:jjad038. doi: 10.1093.
PubMed Abstract available

STEENHOLDT C, Ovesen PD, Brynskov J, Seidelin JB, et al
Tofacitinib for acute severe ulcerative colitis: a systematic review.
J Crohns Colitis. 2023 Mar 1:jjad036. doi: 10.1093.
PubMed Abstract available

February 2023

LOWENBERG M, Volkers A, van Gennep S, Mookhoek A, et al
Mercaptopurine for the treatment of ulcerative colitis - a randomised placebo-controlled trial.
J Crohns Colitis. 2023 Feb 27:jjad022. doi: 10.1093.
PubMed Abstract available

LAHARIE D, Mary JY
Should we target complete endoscopic healing in patients with acute severe ulcerative colitis?
J Crohns Colitis. 2023 Feb 25:jjad032. doi: 10.1093.
PubMed Abstract available

QUEIROZ NSF, Cheifetz AS, Papamichael K
Going Beyond a Treat-To-Target to a Treat-To-Clear and a Treat-To-Trough Therapeutic Strategy in Patients with Inflammatory Bowel Disease?
J Crohns Colitis. 2023 Feb 24:jjad014. doi: 10.1093.
PubMed

WONG ECL, Dulai PS, Hasan B, Marshall JK, et al
Combined Histologic and Endoscopic Endpoints at Post-induction Lack Additional Prognostic Value Compared to Endoscopic Improvement Alone in Ulcerative Colitis: A Post-hoc Analysis of the VARSITY study.
J Crohns Colitis. 2023 Feb 23:jjad033. doi: 10.1093.
PubMed Abstract available

WINOGRODZKI T, Metwaly A, Grodziecki A, Liang W, et al
TNF DeltaARE pigs: a translational Crohn;s Disease model.
J Crohns Colitis. 2023 Feb 23:jjad034. doi: 10.1093.
PubMed Abstract available

RIBALDONE DG, Vieujean S, Julsgaard M, Armandi A, et al
Non-hepatic solid organ transplant in patients with inflammatory bowel disease: an ECCO CONFER Multicentre Case Series.
J Crohns Colitis. 2023 Feb 23:jjad030. doi: 10.1093.
PubMed Abstract available

AHMAD HA, East JE, Panaccione R, Travis S, et al
Artificial Intelligence in Inflammatory Bowel Disease Endoscopy: Implications for Clinical Trials.
J Crohns Colitis. 2023 Feb 22:jjad029. doi: 10.1093.
PubMed Abstract available

MENG G, Monaghan TM, Duggal NA, Tighe P, et al
Microbial-Immune Crosstalk in Elderly-Onset Inflammatory Bowel Disease: Unchartered Territory.
J Crohns Colitis. 2023 Feb 20:jjad025. doi: 10.1093.
PubMed Abstract available

WANG Z, Gong J
Causal effect of visceral adipose tissue accumulation on the inflammatory bowel disease: a Mendelian randomization study.
J Crohns Colitis. 2023 Feb 20:jjad026. doi: 10.1093.
PubMed

RISPO A, Calabrese G, Testa A, Imperatore N, et al
Hocus Pocus: The Role Of Handheld Ultrasonography In Predicting Disease Extension And Endoscopic Activity In Ulcerative Colitis.
J Crohns Colitis. 2023 Feb 16:jjad024. doi: 10.1093.
PubMed Abstract available

REZAZADEH ARDABILI A, van Esser D, Wintjens D, Cilissen M, et al
Development and validation of a remote monitoring tool for assessment of mild, moderate, and severe infections in Inflammatory Bowel Disease.
J Crohns Colitis. 2023 Feb 16:jjad023. doi: 10.1093.
PubMed Abstract available

DONNELLY M, Ryan OK, Ryan EJ, Bass GA, et al
Comparison of restorative proctocolectomy with and without defunctioning loop ileostomy in patients with ulcerative colitis - A systematic review and meta-analysis.
J Crohns Colitis. 2023 Feb 13:jjad021. doi: 10.1093.
PubMed Abstract available

Corrigendum to: Long-term Oncological Outcome of Segmental Versus Extended Colectomy for Colorectal Cancer in Crohn's Disease: Results from an International Multicentre Study.
J Crohns Colitis. 2023 Feb 9:jjac158. doi: 10.1093.
PubMed

SCHREIBER S, Feagan BG, Peyrin-Biroulet L, Vermeire S, et al
Filgotinib Improved Health-Related Quality of Life and Led to Comprehensive Disease Control in Individuals with Ulcerative Colitis: Data from SELECTION.
J Crohns Colitis. 2023 Feb 9:jjad018. doi: 10.1093.
PubMed Abstract available

REENAERS C, Gillard RP, Coimbra C, Gillard RM, et al
Clinical and MRI evolution after local injection of bone marrow-derived mesenchymal stem cells in perianal fistulae in Crohn's disease: results from a prospective monocentric study.
J Crohns Colitis. 2023 Feb 3:jjac192. doi: 10.1093.
PubMed Abstract available

January 2023

VERSTOCKT B, Pouillon L, Ballaux F, Jorissen C, et al
Patient reported outcomes and disability are associated with histological disease activity in patients with ulcerative colitis: results from the APOLLO study.
J Crohns Colitis. 2023 Jan 27:jjad015. doi: 10.1093.
PubMed Abstract available

VERBURGT CM, Dunn KA, Ghiboub M, Lewis JD, et al
Successful Dietary Therapy in Paediatric Crohn's Disease is Associated with Shifts in Bacterial Dysbiosis and Inflammatory Metabotype Towards Healthy Controls.
J Crohns Colitis. 2023;17:61-72.
PubMed Abstract available

SHARIP MT, Subramanian S
IBD Risk-It Is All in the Family!
J Crohns Colitis. 2023;17:28-29.
PubMed

TORRES J, Chaparro M, Julsgaard M, Katsanos K, et al
European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation.
J Crohns Colitis. 2023;17:1-27.
PubMed

CASAS-DEZA D, Lamuela-Calvo LJ, Gomollon F, Arbones-Mainar JM, et al
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry.
J Crohns Colitis. 2023;17:83-91.
PubMed Abstract available

AMIOT A, Rahier JF, Baert F, Nahon S, et al
The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study.
J Crohns Colitis. 2023;17:37-48.
PubMed Abstract available

SIMSEK M, Schepers F, Kaplan S, van Asseldonk D, et al
Thioguanine is effective as maintenance therapy for inflammatory bowel disease: a prospective multicentre registry study.
J Crohns Colitis. 2023 Jan 25:jjad013. doi: 10.1093.
PubMed Abstract available

SHUBHAKAR A, Jansen BC, Adams AT, Reiding KR, et al
Serum N-Glycomic Biomarkers Predict Treatment Escalation in Inflammatory Bowel Disease.
J Crohns Colitis. 2023 Jan 24:jjad012. doi: 10.1093.
PubMed Abstract available

CHANG MJ, Hao JW, Qiao J, Chen MR, et al
A compendium of mucosal molecular characteristics provides novel perspectives on the treatment of ulcerative colitis.
J Crohns Colitis. 2023 Jan 22:jjad011. doi: 10.1093.
PubMed Abstract available

CAO S, Colonna M, Deepak P
Pathogenesis of Perianal Fistulizing Crohn's Disease: Current knowledge, gaps in understanding and future research directions.
J Crohns Colitis. 2023 Jan 19:jjad008. doi: 10.1093.
PubMed Abstract available

SOSNOVSKI KE, Braun T, Amir A, Moshel D, et al
GATA6-AS1 regulates intestinal epithelial mitochondrial functions, and its reduced expression is linked to intestinal inflammation and less favorable disease course in ulcerative colitis (UC).
J Crohns Colitis. 2023 Jan 19:jjad006. doi: 10.1093.
PubMed Abstract available

SUN Z, Liu MS
Genetic evidence for causal relationship between body mass index and inflammatory bowel disease: a Mendelian randomisation study.
J Crohns Colitis. 2023 Jan 19:jjad007. doi: 10.1093.
PubMed

GISBERT JP, Garcia MJ, Chaparro M
Rescue therapies for steroid-refractory acute severe ulcerative colitis: A review.
J Crohns Colitis. 2023 Jan 18:jjad004. doi: 10.1093.
PubMed Abstract available

NOOR NM, Sousa P, Bettenworth D, Gomollon F, et al
ECCO Topical Review on Biological Treatment Cycles in Crohn's Disease.
J Crohns Colitis. 2023 Jan 10:jjad001. doi: 10.1093.
PubMed Abstract available

Corrigendum to: Efficacy and Outcomes of Faecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease.
J Crohns Colitis. 2023 Jan 4:jjac195. doi: 10.1093.
PubMed

December 2022

Erratum to: Tofacitinib for the Treatment of Ulcerative Colitis: An Integrated Summary of up to 7.8 Years of Safety Data from the Global Clinical Programme.
J Crohns Colitis. 2022 Dec 29:jjac180. doi: 10.1093.
PubMed

CHEN J, Zhou Y, Sun Y, Yuan S, et al
Bi-directional Mendelian randomization analysis provides evidence for the causal involvement of dysregulation of CXCL9, CCL11 and CASP8 in the pathogenesis of ulcerative colitis.
J Crohns Colitis. 2022 Dec 28:jjac191. doi: 10.1093.
PubMed Abstract available

JE Y, Han K, Chun J, Kim Y, et al
Association of Waist Circumference with the Risk of Inflammatory Bowel Disease: a Nationwide Cohort Study of 10 Million Individuals in Korea.
J Crohns Colitis. 2022 Dec 23:jjac193. doi: 10.1093.
PubMed Abstract available

WETWITTAYAKHLANG P, Gonczi L, Lakatos L, Kurti Z, et al
Long-term Colectomy rates of Ulcerative Colitis over 40-year of Different Therapeutic eras - Results from Western Hungarian Population-based Inception Cohort between 1977-2020.
J Crohns Colitis. 2022 Dec 20:jjac188. doi: 10.1093.
PubMed Abstract available

GORDON H, Biancone L, Fiorino G, Katsanos KH, et al
ECCO Guidelines on Inflammatory Bowel Disease and Malignancies.
J Crohns Colitis. 2022 Dec 18:jjac187. doi: 10.1093.
PubMed

TAKAHASHI K, Shigeyasu K, Kondo Y, Gotoh K, et al
RNA editing is a valuable biomarker for predicting carcinogenesis in ulcerative colitis.
J Crohns Colitis. 2022 Dec 18:jjac186. doi: 10.1093.
PubMed Abstract available

TAKENAKA K, Kawamoto A, Kitazume Y, Fujii T, et al
Transmural remission characterized by high biologic concentrations demonstrates better prognosis in Crohn's disease.
J Crohns Colitis. 2022 Dec 17:jjac185. doi: 10.1093.
PubMed Abstract available

KHALILI H, Hakansson N, Casey K, Lopes E, et al
Diet Quality and Risk of Older-Onset Crohn's Disease and Ulcerative Colitis.
J Crohns Colitis. 2022 Dec 15:jjac184. doi: 10.1093.
PubMed Abstract available

CROUWEL F, Simsek M, de Boer MA, Mulder CJJ, et al
Exposure to thioguanine during 117 pregnancies in women with inflammatory bowel disease.
J Crohns Colitis. 2022 Dec 15:jjac183. doi: 10.1093.
PubMed Abstract available

UCHIYAMA K, Takagi T, Mizushima K, Hirai Y, et al
Mucosal addressin cell adhesion molecule 1 expression reflects mucosal inflammation and subsequent relapse in patients with ulcerative colitis.
J Crohns Colitis. 2022 Dec 13:jjac182. doi: 10.1093.
PubMed Abstract available

HAMON A, Cazals-Hatem D, Stefanescu C, Uzzan M, et al
Crohn-like disease affecting small bowel due to monogenic SLCO2A1 mutations: First cases of Chronic Enteropathy Associated with SLCO2A1 gene (CEAS) in France.
J Crohns Colitis. 2022 Dec 8:jjac181. doi: 10.1093.
PubMed Abstract available

YANAI H, Kagramanova A, Knyazev O, Sabino J, et al
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study.
J Crohns Colitis. 2022;16:1882-1892.
PubMed Abstract available

LIU Z, Julsgaard M, Zhu X, Martin J, et al
Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children.
J Crohns Colitis. 2022;16:1835-1844.
PubMed Abstract available

BHAT S, Rieder F
Hypoxia-Inducible Factor 1-Alpha Stabilizers in the Treatment of Inflammatory Bowel Diseases: Oxygen as a Novel IBD Therapy?
J Crohns Colitis. 2022;16:1924-1932.
PubMed Abstract available

MITROVA K, Pipek B, Bortlik M, Bouchner L, et al
Safety of Ustekinumab and Vedolizumab During Pregnancy-Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study.
J Crohns Colitis. 2022;16:1808-1815.
PubMed Abstract available

HAMILTON AL, De Cruz P, Wright EK, Dervieux T, et al
Non-invasive Serological Monitoring for Crohn's Disease Postoperative Recurrence.
J Crohns Colitis. 2022;16:1797-1807.
PubMed Abstract available

LEE C, Song JH, Cha YE, Chang DK, et al
Intestinal Epithelial Responses to IL-17 in Adult Stem Cell-derived Human Intestinal Organoids.
J Crohns Colitis. 2022;16:1911-1923.
PubMed Abstract available

PELLINO G, Rottoli M, Mineccia M, Frontali A, et al
Segmental Versus Total Colectomy for Crohn's Disease in the Biologic Era: Results From The SCOTCH International, Multicentric Study.
J Crohns Colitis. 2022;16:1853-1861.
PubMed Abstract available

ARP L, Jansson S, Wewer V, Burisch J, et al
Psychiatric Disorders in Adult and Paediatric Patients With Inflammatory Bowel Diseases - A Systematic Review and Meta-Analysis.
J Crohns Colitis. 2022;16:1933-1945.
PubMed Abstract available

BARBERIO B, Savarino E, Verstockt B, Fumery M, et al
Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series.
J Crohns Colitis. 2022;16:1845-1852.
PubMed Abstract available

BATTAT R
Serum Monitoring of Recurrence in Post-Operative Crohn's Disease: Have We Arrived?
J Crohns Colitis. 2022;16:1795-1796.
PubMed

MAHAJNA H, Verstockt B, Bergemalm D, Castiglione F, et al
Idiopathic Thrombocytopenic Purpura associated with Inflammatory Bowel Disease: a multi-centre ECCO CONFER case series.
J Crohns Colitis. 2022 Dec 2:jjac179. doi: 10.1093.
PubMed Abstract available

November 2022

EL-ZIMAITY H, Shaffer SR, Riddell RH, Pai RK, et al
Beyond Neutrophils for predicting relapse and remission in ulcerative colitis.
J Crohns Colitis. 2022 Nov 25:jjac178. doi: 10.1093.
PubMed Abstract available

KONTOLA K, Oksanen P, Huhtala H, Jussila A, et al
Increasing incidence of inflammatory bowel disease with greatest change among the elderly: a nationwide study in Finland, 2000-2020.
J Crohns Colitis. 2022 Nov 24:jjac177. doi: 10.1093.
PubMed Abstract available

FIOCCHI C, Iliopoulos D
Numbers Do Not Lie: The Dire Need for New Directions in IBD.
J Crohns Colitis. 2022;16:1649-1650.
PubMed

KRUIS W, Siegmund B, Lesniakowski K, Simanenkov V, et al
Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial.
J Crohns Colitis. 2022;16:1714-1724.
PubMed Abstract available

ZUO L, Li J, Zhang X, Geng Z, et al
Aberrant Mesenteric Adipose Extracellular Matrix Remodelling is Involved in Adipocyte Dysfunction in Crohn's Disease: The Role of TLR-4-mediated Macrophages.
J Crohns Colitis. 2022;16:1762-1776.
PubMed Abstract available

BACHOUR SP, Shah RS, Rieder F, Qazi T, et al
Intra-abdominal septic complications after ileocolic resection increases risk for endoscopic and surgical postoperative Crohn's disease recurrence.
J Crohns Colitis. 2022;16:1696-1705.
PubMed Abstract available

BERERA S, Ioannou SC, Morillo D, Mantero AMA, et al
Combining Pentoxifylline With Vedolizumab for Crohn's Disease: Results of a Randomised, Placebo-controlled Pilot Study.
J Crohns Colitis. 2022;16:1687-1695.
PubMed Abstract available

KORI M, Zamir Y, Yermiyahu SO, Ainbinder I, et al
The association of Inflammatory Bowel Disease with Celiac Disease and Celiac Autoimmunity in children and adults: A nationwide study from the epi-IIRN.
J Crohns Colitis. 2022 Nov 17. pii: 6832168. doi: 10.1093.
PubMed Abstract available

KUMAR L, Doherty G
The Tortoise (Endoscopy-Driven Treatment) and the Hare (Prophylactic Treatment): Who Wins the Race to Beat Post-Operative Recurrence of Crohn's Disease?
J Crohns Colitis. 2022 Nov 17:jjac165. doi: 10.1093.
PubMed

VAN DER DOES DE WILLEBOIS EML, Duijvestein M, Wasmann KA, D'Haens GRAM, et al
Endoscopic Recurrence or Anastomotic Wound Healing Phenomenon after Ileocolic Resection for Crohn's Disease: The Challenges of Accurate Endoscopic Scoring.
J Crohns Colitis. 2022 Nov 16:jjac175. doi: 10.1093.
PubMed Abstract available

BATTAT R, Scherl EJ, Lukin D, Charilaou P, et al
Increased Primary Bile Acids with Ileocolonic Resection Impact Ileal Inflammation and Gut Microbiota in Inflammatory Bowel Disease.
J Crohns Colitis. 2022 Nov 2. pii: 6794155. doi: 10.1093.
PubMed Abstract available

ELLUL P, Schembri J, Baldacchino VA, Molnar T, et al
Post-inflammatory polyps burden as a prognostic marker of disease-outcome in patients with inflammatory bowel disease.
J Crohns Colitis. 2022 Nov 2. pii: 6794125. doi: 10.1093.
PubMed Abstract available

DUPONT-LUCAS C, Leroyer A, Ley D, Spyckerelle C, et al
Increased risk of cancer and mortality in a large French population-based paediatric-onset inflammatory bowel disease retrospective cohort.
J Crohns Colitis. 2022 Nov 1. pii: 6783208. doi: 10.1093.
PubMed Abstract available

BOUCHER D, Barnich N
Phage Therapy Against Adherent-invasive E. coli: Towards a Promising Treatment of Crohn's Disease Patients?
J Crohns Colitis. 2022;16:1509-1510.
PubMed

DAL BUONO A, Faita F, Peyrin-Biroulet L, Danese S, et al
Ultrasound Elastography in Inflammatory Bowel Diseases: A Systematic Review of Accuracy Compared with Histopathological Assessment.
J Crohns Colitis. 2022;16:1637-1646.
PubMed Abstract available

DE VOOGD F, Bots S, Gecse K, Gilja OH, et al
Intestinal Ultrasound Early on in Treatment Follow-up Predicts Endoscopic Response to Anti-TNFalpha Treatment in Crohn's Disease.
J Crohns Colitis. 2022;16:1598-1608.
PubMed Abstract available

DUBINSKY V, Reshef L, Rabinowitz K, Wasserberg N, et al
Escherichia coli Strains from Patients with Inflammatory Bowel Diseases have Disease-specific Genomic Adaptations.
J Crohns Colitis. 2022;16:1584-1597.
PubMed Abstract available

MONFORT-FERRE D, Caro A, Menacho M, Marti M, et al
The Gut Microbiota Metabolite Succinate Promotes Adipose Tissue Browning in Crohn's Disease.
J Crohns Colitis. 2022;16:1571-1583.
PubMed Abstract available

HU S, Mok J, Gowans M, Ong DEH, et al
Oral Microbiome of Crohn's Disease Patients With and Without Oral Manifestations.
J Crohns Colitis. 2022;16:1628-1636.
PubMed Abstract available

KUMAR S, Parry T, Mallett S, Bhatnagar G, et al
Diagnostic Performance of Magnetic Resonance Enterography Disease Activity Indices Compared with a Histological Reference Standard for Adult Terminal Ileal Crohn's Disease: Experience from the METRIC Trial.
J Crohns Colitis. 2022;16:1531-1539.
PubMed Abstract available

October 2022

BARRAU M, Duprat M, Veyrard P, Tournier Q, et al
A Systematic Review on the interest of Drug Tolerant assay in the monitoring of Inflammatory Bowel Disease.
J Crohns Colitis. 2022 Oct 27. pii: 6775962. doi: 10.1093.
PubMed Abstract available

LE HD, Pflaum T, Labrenz J, Sari S, et al
Interobserver reliability of the Nancy index for ulcerative colitis: An assessment of the practicability and ease of use in a single-centre real-world setting.
J Crohns Colitis. 2022 Oct 25. pii: 6773056. doi: 10.1093.
PubMed Abstract available

TARGOWNIK L, Dubinsky MC, Steinwurz F, Bushmakin AG, et al
Disease Activity and Health-related Quality of Life Relationships with Work Productivity in Patients with Ulcerative Colitis in OCTAVE Induction 1&2 and OCTAVE Sustain.
J Crohns Colitis. 2022 Oct 22. pii: 6769962. doi: 10.1093.
PubMed Abstract available

BYRNE MF, Panaccione R, East JE, Iacucci M, et al
Application of Deep Learning Models to Improve Ulcerative Colitis Endoscopic Disease Activity Scoring Under Multiple Scoring Systems.
J Crohns Colitis. 2022 Oct 18. pii: 6762568. doi: 10.1093.
PubMed Abstract available

Erratum to: Prevalence and Outcomes of COVID-19 Among Patients With Inflammatory Bowel Disease-A Danish Prospective Population-based Cohort Study.
J Crohns Colitis. 2022 Oct 17. pii: 6761987. doi: 10.1093.
PubMed

FOLLIN-ARBELET B, Milada SC, Hovde O, Jelsness-Jorgensen LP, et al
Mortality in patients with Inflammatory Bowel Disease: Results from 30 years of follow-up in a Norwegian inception cohort (the IBSEN study).
J Crohns Colitis. 2022 Oct 14. pii: 6761119. doi: 10.1093.
PubMed Abstract available

VIEUJEAN S, Moens A, Hassid D, Rothfuss K, et al
Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease - A case series.
J Crohns Colitis. 2022 Oct 12. pii: 6759599. doi: 10.1093.
PubMed Abstract available

OTERO-PINEIRO AM, Jia X, Pedersen KE, Hull T, et al
Surgical Intervention is Effective for the Treatment of Crohn's related Rectovaginal Fistulas: Experience From A Tertiary Inflammatory Bowel Disease Practice.
J Crohns Colitis. 2022 Oct 11. pii: 6758392. doi: 10.1093.
PubMed Abstract available

BAHNAM P, Hanzel J, Ma C, Zou L, et al
Most placebo-controlled trials in inflammatory bowel disease were underpowered because of overestimated drug efficacy rates: Results from a systematic review of induction studies.
J Crohns Colitis. 2022 Oct 11. pii: 6758390. doi: 10.1093.
PubMed Abstract available

NYSTROM N, Prast-Nielsen S, Correia M, Globisch D, et al
Mucosal and plasma metabolomes in new-onset paediatric inflammatory bowel disease: correlations with disease characteristics and plasma inflammation protein markers.
J Crohns Colitis. 2022 Oct 11. pii: 6758389. doi: 10.1093.
PubMed Abstract available

HANZEL J, Bossuyt P, Pittet V, Samaan M, et al
Development of a Core Outcome Set for Real-World Data in Inflammatory Bowel Disease: A European Crohn's and Colitis Organisation (ECCO) Position Paper.
J Crohns Colitis. 2022 Oct 3. pii: 6747109. doi: 10.1093.
PubMed Abstract available

September 2022

SCHOEFS E, Vermeire S, Ferrante M, Sabino J, et al
What are the unmet needs and most relevant treatment outcomes according to patients with inflammatory bowel disease? A qualitative patient preference study.
J Crohns Colitis. 2022 Sep 27. pii: 6722595. doi: 10.1093.
PubMed Abstract available

CROFT NM, de Ridder L, Griffiths AM, Hyams JS, et al
Paediatric inflammatory bowel disease: a multi-stakeholder perspective to improve development of drugs for children and adolescents.
J Crohns Colitis. 2022 Sep 21. pii: 6710188. doi: 10.1093.
PubMed Abstract available

LOUIS E, Siegel CA, James B, Heidenreich S, et al
Patients with Inflammatory Bowel Disease Have Heterogeneous Treatment Preferences That Are Largely Determined by the Avoidance of Abdominal Pain and Side Effects [P-POWER IBD Study].
J Crohns Colitis. 2022 Sep 20. pii: 6708291. doi: 10.1093.
PubMed Abstract available

Erratum to: You Are What You Eat? Growing Evidence That Diet Influences the Risk of Inflammatory Bowel Disease.
J Crohns Colitis. 2022 Sep 19. pii: 6706938. doi: 10.1093.
PubMed

KURTI Z, Gonczi L, Lakatos L, Golovics P, et al
Epidemiology, treatment strategy, natural disease course and surgical outcomes of patients with ulcerative colitis in Western Hungary - a population-based study between 2007 and 2018, data from the Veszprem County cohort.
J Crohns Colitis. 2022 Sep 19. pii: 6705518. doi: 10.1093.
PubMed Abstract available

DORN-RASMUSSEN M, Lo B, Zhao M, Kaplan GG, et al
The incidence and prevalence of paediatric- and adult-onset inflammatory bowel disease in Denmark during a 37-year period - a nationwide cohort study (1980-2017).
J Crohns Colitis. 2022 Sep 19. pii: 6705459. doi: 10.1093.
PubMed Abstract available

WEWER MD, Langholz E, Munkholm P, Bendtsen F, et al
Disease Activity Patterns of Inflammatory Bowel Disease - A Danish Nationwide Cohort Study 1995-2018.
J Crohns Colitis. 2022 Sep 19. pii: 6705004. doi: 10.1093.
PubMed Abstract available

SANDBORN WJ, D'Haens GR, Sands BE, Panaccione R, et al
Tofacitinib for the treatment of ulcerative colitis: an integrated summary of up to 7.8 years of safety data from the global clinical program.
J Crohns Colitis. 2022 Sep 17. pii: 6702643. doi: 10.1093.
PubMed Abstract available

MORTLOCK S, Lord A, Montgomery G, Zakrzewski M, et al
An extremes of phenotype approach confirms significant genetic heterogeneity in patients with ulcerative colitis.
J Crohns Colitis. 2022 Sep 16. pii: 6701957. doi: 10.1093.
PubMed Abstract available

OLIVERA PA, Lasa JS, Zubiaurre I, Jairath V, et al
Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
J Crohns Colitis. 2022 Sep 10. pii: 6695362. doi: 10.1093.
PubMed Abstract available

DREWES AM
Pain in Patients with Crohn's and Colitis: Can We Solve the Puzzle?
J Crohns Colitis. 2022;16:1345-1346.
PubMed

MAGRO F, Estevinho MM
COVID-19 Vaccines in IBD Patients: Particularities and Future Perspectives.
J Crohns Colitis. 2022;16:1343-1344.
PubMed

SMITH PJ, Critchley L, Storey D, Gregg B, et al
Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study.
J Crohns Colitis. 2022;16:1436-1446.
PubMed Abstract available

XU C, Jiang W, Wang L, Mao X, et al
Intestinal Ultrasound for Differentiating Fibrotic or Inflammatory Stenosis in Crohn's Disease: A Systematic Review and Meta-analysis.
J Crohns Colitis. 2022;16:1493-1504.
PubMed Abstract available

BURRELLO C, Strati F, Lattanzi G, Diaz-Basabe A, et al
IL10 Secretion Endows Intestinal Human iNKT Cells with Regulatory Functions Towards Pathogenic T Lymphocytes.
J Crohns Colitis. 2022;16:1461-1474.
PubMed Abstract available

SAVELKOUL EHJ, Maas MHJ, Bourgonje AR, Crouwel F, et al
Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn's Disease.
J Crohns Colitis. 2022;16:1372-1379.
PubMed Abstract available

SONNENBERG A, Genta RM
Temporal changes in the histology of microscopic colitis.
J Crohns Colitis. 2022;16:1415-1419.
PubMed Abstract available

DOHERTY J, Morain NO, Stack R, Girod P, et al
Reduced Serological Response to COVID-19 Vaccines in Patients with IBD is Further Diminished by TNF Inhibitor Therapy; Early Results of the VARIATION study [VAriability in Response in IBD Against SARS-COV-2 ImmunisatiON].
J Crohns Colitis. 2022;16:1354-1362.
PubMed Abstract available

August 2022

VITALI R, Palone F, Armuzzi A, Fulci V, et al
Proteomic analysis identifies three reliable biomarkers of intestinal inflammation in the stools of patients with Inflammatory Bowel Disease.
J Crohns Colitis. 2022 Aug 30. pii: 6679173. doi: 10.1093.
PubMed Abstract available

JULIEN C, Anakok E, Treton X, Nachury M, et al
Impact of the Ileal Microbiota on Surgical Site Infections in Crohn's Disease: A Nationwide Prospective Cohort.
J Crohns Colitis. 2022;16:1211-1221.
PubMed Abstract available

BRETON J, Tanes C, Tu V, Albenberg L, et al
A Microbial Signature for Paediatric Perianal Crohn's Disease.
J Crohns Colitis. 2022;16:1281-1292.
PubMed Abstract available

SUDHAKAR P, Alsoud D, Wellens J, Verstockt S, et al
Tailoring Multi-omics to Inflammatory Bowel Diseases: All for One and One for All.
J Crohns Colitis. 2022;16:1306-1320.
PubMed Abstract available

NGOLLO M, Perez K, Hammoudi N, Gorelik Y, et al
Identification of Gene Expression Profiles Associated with an Increased Risk of Post-Operative Recurrence in Crohn's Disease.
J Crohns Colitis. 2022;16:1269-1280.
PubMed Abstract available

KALLA R, Adams AT, Nowak JK, Bergemalm D, et al
Analysis of systemic epigenetic alterations in inflammatory bowel disease: defining geographical, genetic, and immune-inflammatory influences on the circulating methylome.
J Crohns Colitis. 2022 Aug 27. pii: 6677995. doi: 10.1093.
PubMed Abstract available

LOFTUS EV, Vermeire S, Feagan BG, Le Brun FO, et al
Corticosteroid-sparing Effects of Filgotinib in Moderate to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study.
J Crohns Colitis. 2022 Aug 25. pii: 6675518. doi: 10.1093.
PubMed Abstract available

NARULA N, Merat S, Liu D, Pugatch D, et al
Time to endorse a sensitive method for scoring endoscopic activity of ulcerative colitis in clinical research.
J Crohns Colitis. 2022 Aug 24. pii: 6674697. doi: 10.1093.
PubMed Abstract available

JOUSTRA V, Hageman IL, Satsangi J, Adams A, et al
Systematic Review and Meta-analysis of Peripheral Blood DNA methylation studies in Inflammatory Bowel Disease.
J Crohns Colitis. 2022 Aug 23. pii: 6674036. doi: 10.1093.
PubMed Abstract available

Corrigendum to: P169 Vitamin D levels are inversely associated with inflammation in pediatric Inflammatory Bowel Disease patients.
J Crohns Colitis. 2022 Aug 22. pii: 6673037. doi: 10.1093.
PubMed

LIN V, Gogenur S, Pachler F, Fransgaard T, et al
Risk prediction for complications in Inflammatory Bowel Disease surgery: External validation of the American College of Surgeons' National Surgical Quality Improvement Program Surgical Risk Calculator.
J Crohns Colitis. 2022 Aug 17. pii: 6668838. doi: 10.1093.
PubMed Abstract available

HONAP S, Irving PM, Samaan MA
Ustekinumab-Induced Inflammatory Demyelinating Polyneuropathy in a Patient with Ulcerative Colitis.
J Crohns Colitis. 2022 Aug 12. pii: 6663939. doi: 10.1093.
PubMed

CARON B, D'Amico F, Jairath V, Netter P, et al
Available methods for benefit-risk assessment: lessons for inflammatory bowel disease drugs.
J Crohns Colitis. 2022 Aug 11. pii: 6661406. doi: 10.1093.
PubMed Abstract available

HARVEY PR, Coupland B, Mytton J, De Silva S, et al
Venous thromboembolism following discharge from hospital in patients admitted for inflammatory bowel disease.
J Crohns Colitis. 2022 Aug 10. pii: 6660709. doi: 10.1093.
PubMed Abstract available

TORRES J, Gomes C, Jensen C, Agrawal M, et al
Risk factors for developing Inflammatory Bowel Disease Within and Across Families with Family History of IBD.
J Crohns Colitis. 2022 Aug 9. pii: 6659033. doi: 10.1093.
PubMed Abstract available

LIU X, Ren X, Zhou L, Liu K, et al
Tollip Orchestrates Macrophage Polarization to Alleviate Intestinal Mucosal Inflammation.
J Crohns Colitis. 2022;16:1151-1167.
PubMed Abstract available

NARULA N, Pray C, Wong ECL, Colombel JF, et al
Categorising Endoscopic Severity of Crohn's Disease Using the Modified Multiplier SES-CD [MM-SES-CD].
J Crohns Colitis. 2022;16:1011-1019.
PubMed Abstract available

HUANG L, Qian W, Xu Y, Guo Z, et al
Mesenteric Adipose Tissue Contributes to Intestinal Fibrosis in Crohn's Disease Through the ATX-LPA Axis.
J Crohns Colitis. 2022;16:1124-1139.
PubMed Abstract available

BARREIRO-DE ACOSTA M, Riestra S, Calafat M, Soto MP, et al
Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU.
J Crohns Colitis. 2022;16:1049-1058.
PubMed Abstract available

FIERENS L, Liefferinckx C, Hoefkens E, Lobaton T, et al
Introduction of Subcutaneous Infliximab CT-P13 and Vedolizumab in Clinical Practice: A Multi-Stakeholder Position Statement Highlighting the Need for Post-Marketing Studies.
J Crohns Colitis. 2022;16:1059-1069.
PubMed Abstract available

ABD EL AZIZ MA, Abdalla S, Calini G, Saeed H, et al
Postoperative Safety Profile of Minimally Invasive Ileocolonic Resections for Crohn's Disease in the Era of Biologic Therapy.
J Crohns Colitis. 2022;16:1079-1088.
PubMed Abstract available

GAO H, He Q, Xu C, Pang Z, et al
The Development and Validation of Anti-paratuberculosis-nocardia Polypeptide Antibody [Anti-pTNP] for the Diagnosis of Crohn's Disease.
J Crohns Colitis. 2022;16:1110-1123.
PubMed Abstract available

CROUWEL F, Buiter HJC, de Boer NK
The Thiopurine Tale: An Unexpected Journey.
J Crohns Colitis. 2022;16:1177-1183.
PubMed Abstract available

DOUADI C, Vazeille E, Chambon C, Hebraud M, et al
Anti-TNF Agents Restrict Adherent-invasive Escherichia coli Replication Within Macrophages Through Modulation of Chitinase 3-like 1 in Patients with Crohn's Disease.
J Crohns Colitis. 2022;16:1140-1150.
PubMed Abstract available

ATIA O, Kang B, Orlansky-Meyer E, Ledder O, et al
Existing Prediction Models of Disease Course in Paediatric Crohn's Disease Are Poorly Replicated in a Prospective Inception Cohort.
J Crohns Colitis. 2022;16:1039-1048.
PubMed Abstract available

July 2022

DIRVANSKYTE P, Gurram B, Bolton C, Warner N, et al
Chromosomal numeric aberrations and rare copy number variation in patients with inflammatory bowel disease.
J Crohns Colitis. 2022 Jul 30. pii: 6652479. doi: 10.1093.
PubMed Abstract available

WONG D, Matini L, Kormilitzin A, Kantschuster R, et al
Patient Reported Outcomes: the ICHOM Standard Set for inflammatory bowel disease in real life practice helps quantify deficits in current care.
J Crohns Colitis. 2022 Jul 22. pii: 6648780. doi: 10.1093.
PubMed Abstract available

YARUR AJ
Intestinal Tissue Levels of Anti-Tumour Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases: Are We Looking in The Right Place at The Right Time?
J Crohns Colitis. 2022;16:869-870.
PubMed

MAGRO F, Sabino J, Rosini F, Tripathi M, et al
ECCO Position on Harmonisation of Crohn's Disease Mucosal Histopathology.
J Crohns Colitis. 2022;16:876-883.
PubMed Abstract available

SENSI B, Khan J, Warusavitarne J, Nardi A, et al
Long-term Oncological Outcome of Segmental Versus Extended Colectomy for Colorectal Cancer in Crohn's Disease: Results from an International Multicentre Study.
J Crohns Colitis. 2022;16:954-962.
PubMed Abstract available

CHAKRABORTY R, Maltz MR, Del Castillo D, Tandel PN, et al
Selective Targeting of Tumour Necrosis Factor Receptor 1 Induces Stable Protection from Crohn's-Like Ileitis in TNFDeltaARE Mice.
J Crohns Colitis. 2022;16:978-991.
PubMed Abstract available

PETERS V, Bolte L, Schuttert EM, Andreu-Sanchez S, et al
Western and Carnivorous Dietary Patterns are Associated with Greater Likelihood of IBD Development in a Large Prospective Population-based Cohort.
J Crohns Colitis. 2022;16:931-939.
PubMed Abstract available

CARON B, Sandborn WJ, Panaccione R, Schreiber S, et al
Efficacy of Pharmacological Agents for Ulcerative Proctitis: A Systematic Literature Review.
J Crohns Colitis. 2022;16:922-930.
PubMed Abstract available

WALSHE M, Nayeri S, Ji J, Hernandez-Rocha C, et al
A Role for CXCR3 Ligands as Biomarkers of Post-Operative Crohn's Disease Recurrence.
J Crohns Colitis. 2022;16:900-910.
PubMed Abstract available

SWAMINATHAN A, Borichevsky GM, Edwards TS, Hirschfeld E, et al
Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Inflammatory Bowel Disease.
J Crohns Colitis. 2022 Jul 8. pii: 6634254. doi: 10.1093.
PubMed Abstract available

June 2022

ZHANG R, Lauwers GY, Choi WT
Increased Risk of Non-Conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
J Crohns Colitis. 2022 Jun 30. pii: 6623587. doi: 10.1093.
PubMed Abstract available

Corrigendum to: ECCO CONFER Investigators, Diagnosis and Outcome of Extranodal Primary Intestinal Lymphoma in Inflammatory Bowel Disease: An ECCO CONFER Case Series.
J Crohns Colitis. 2022 Jun 25. pii: 6617788. doi: 10.1093.
PubMed

HONAP S, Meade S, Spencer A, Pavlidis P, et al
Anogenital Crohn's Disease and Granulomatosis: A Systematic Review of Epidemiology, Clinical Manifestations, and Treatment.
J Crohns Colitis. 2022;16:822-834.
PubMed Abstract available

VIGORITA V, Cano-Valderrama O, Celentano V, Vinci D, et al
Inflammatory Bowel Diseases Benefit from Enhanced Recovery After Surgery [ERAS] Protocol: A Systematic Review with Practical Implications.
J Crohns Colitis. 2022;16:845-851.
PubMed Abstract available

ATIA O, Harel S, Ledderman N, Greenfeld S, et al
Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRN.
J Crohns Colitis. 2022;16:786-795.
PubMed Abstract available

ATIA O, Orlanski-Meyer E, Lujan R, Ledderman N, et al
Improved Outcomes of Paediatric and Adult Crohn's Disease and Association With Emerging Use of Biologics-A Nationwide Study From the Epi-IIRN.
J Crohns Colitis. 2022;16:778-785.
PubMed Abstract available

ALMRADI A, Sedano R, Hogan M, Zou GY, et al
Clinical, Endoscopic, and Safety Placebo Rates in Induction and Maintenance Trials of Crohn's Disease: Meta-Analysis of Randomised Controlled Trials.
J Crohns Colitis. 2022;16:717-736.
PubMed Abstract available

D'HAENS G, Danese S, Davies M, Watanabe M, et al
A phase II, Multicentre, Randomised, Double-Blind, Placebo-controlled Study to Evaluate Safety, Tolerability, and Efficacy of Amiselimod in Patients with Moderate to Severe Active Crohn's Disease.
J Crohns Colitis. 2022;16:746-756.
PubMed Abstract available

ATTAUABI M, Dahlerup JF, Poulsen A, Hansen MR, et al
Outcomes and Long-Term Effects of COVID-19 in Patients with Inflammatory Bowel Diseases - A Danish Prospective Population-Based Cohort Study with Individual-Level Data.
J Crohns Colitis. 2022;16:757-767.
PubMed Abstract available

VAN RIJN KL, Meima-van Praag EM, Bossuyt PM, D'Haens GR, et al
Fibrosis and MAGNIFI-CD Activity Index at Magnetic Resonance Imaging to Predict Treatment Outcome in Perianal Fistulizing Crohn's Disease Patients.
J Crohns Colitis. 2022;16:708-716.
PubMed Abstract available

REENAERS C, Louis E
Progressing Towards the Implementation of a Treat-To-Target Strategy in Perianal Crohn's Disease.
J Crohns Colitis. 2022;16:693-694.
PubMed

ILVEMARK JFKF, Wilkens R, Thielsen P, Dige A, et al
Early intestinal ultrasound predicts intravenous corticosteroid response in hospitalized patients with severe ulcerative colitis.
J Crohns Colitis. 2022 Jun 13. pii: 6607631. doi: 10.1093.
PubMed Abstract available

KIM KO, Kim EY, Lee YJ, Lee HS, et al
Efficacy, safety and tolerability of oral sulfate tablet for bowel preparation in patients with inflammatory bowel disease: Multicenter randomized controlled study.
J Crohns Colitis. 2022 Jun 11. pii: 6605993. doi: 10.1093.
PubMed Abstract available

JAGT JZ, Verburgt CM, de Vries R, de Boer NKH, et al
Faecal metabolomics in paediatric inflammatory bowel disease: a systematic review.
J Crohns Colitis. 2022 Jun 9. pii: 6605030. doi: 10.1093.
PubMed Abstract available

CLARKSTON K, Karns R, Jegga AG, Sharma M, et al
Targeted Assessment of Mucosal Immune Gene Expression Predicts Clinical Outcomes in Children with Ulcerative Colitis.
J Crohns Colitis. 2022 Jun 4. pii: 6602063. doi: 10.1093.
PubMed Abstract available

May 2022

TORRENTE F, Meade S, Benchimol EI, de Ridder L, et al
Thromboprophylaxis use in paediatric inflammatory bowel disease: an international RAND appropriateness panel.
J Crohns Colitis. 2022 May 24. pii: 6591364. doi: 10.1093.
PubMed Abstract available

DANESE S, Peyrin-Biroulet L
Evolution of IL-23 Blockade in Inflammatory Bowel Disease.
J Crohns Colitis. 2022;16.
PubMed

SEWELL GW, Kaser A
Interleukin-23 in the Pathogenesis of Inflammatory Bowel Disease and Implications for Therapeutic Intervention.
J Crohns Colitis. 2022;16.
PubMed Abstract available

PARIGI TL, Iacucci M, Ghosh S
Blockade of IL-23: What is in the Pipeline?
J Crohns Colitis. 2022;16.
PubMed Abstract available

D'AMICO F, Peyrin-Biroulet L, Danese S
Ustekinumab in Crohn's Disease: New Data for Positioning in Treatment Algorithm.
J Crohns Colitis. 2022;16.
PubMed Abstract available

MCDONALD BD, Dyer EC, Rubin DT
IL-23 Monoclonal Antibodies for IBD: So Many, So Different?
J Crohns Colitis. 2022;16.
PubMed Abstract available

VALENTI M, Narcisi A, Pavia G, Gargiulo L, et al
What Can IBD Specialists Learn from IL-23 Trials in Dermatology?
J Crohns Colitis. 2022;16.
PubMed Abstract available

ATREYA R, Neurath MF
IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical Reality.
J Crohns Colitis. 2022;16.
PubMed Abstract available

GOTTLIEB ZS, Sands BE
Personalised Medicine with IL-23 Blockers: Myth or Reality?
J Crohns Colitis. 2022;16.
PubMed Abstract available

CALVET X, Panes J, Gallardo-Escudero J, de la Cuadra-Grande A, et al
Multicriteria Decision Analysis for Updating of Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units in Spain.
J Crohns Colitis. 2022 May 11. pii: 6584605. doi: 10.1093.
PubMed Abstract available

ROGLER G
No Need to Scope? Monitoring of Treatment Response in IBD Patients by Transabdominal Ultrasound.
J Crohns Colitis. 2022;16:521-522.
PubMed

KAKUTA Y, Iwaki H, Umeno J, Kawai Y, et al
Crohn's Disease and Early Exposure to Thiopurines are Independent Risk Factors for Mosaic Chromosomal Alterations in Patients with Inflammatory Bowel Diseases.
J Crohns Colitis. 2022;16:643-655.
PubMed Abstract available

VERBURGT CM, Dunn KA, Van Limbergen JE
Dietary Therapy Reduces Pro-inflammatory Microbiome Features in Paediatric Crohn's Disease.
J Crohns Colitis. 2022;16:682-684.
PubMed

NARULA N, Wong ECL, Colombel JF, Sandborn WJ, et al
Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn's Disease.
J Crohns Colitis. 2022;16:616-624.
PubMed Abstract available

BOTS S, De Voogd F, De Jong M, Ligtvoet V, et al
Point-of-care Intestinal Ultrasound in IBD Patients: Disease Management and Diagnostic Yield in a Real-world Cohort and Proposal of a Point-of-care Algorithm.
J Crohns Colitis. 2022;16:606-615.
PubMed Abstract available

DAOUD ND, Hashash JG, Picco MF, Farraye FA, et al
Faecal Calprotectin from Ileostomy Output Is Sensitive and Specific for the Prediction of Small Bowel Inflammation in Patients with Crohn's Disease.
J Crohns Colitis. 2022;16:601-605.
PubMed Abstract available

KUCHARZIK T, Tielbeek J, Carter D, Taylor SA, et al
ECCO-ESGAR Topical Review on Optimizing Reporting for Cross-Sectional Imaging in Inflammatory Bowel Disease.
J Crohns Colitis. 2022;16:523-543.
PubMed Abstract available

SUN TY, Li YQ, Zhao FQ, Sun HM, et al
MiR-1-3p and MiR-124-3p Synergistically Damage the Intestinal Barrier in the Ageing Colon.
J Crohns Colitis. 2022;16:656-667.
PubMed Abstract available

ALSOUD D, De Hertogh G, Compernolle G, Tops S, et al
Real-world endoscopic and histologic outcomes are correlated with ustekinumab exposure in patients with ulcerative colitis.
J Crohns Colitis. 2022 May 9. pii: 6582859. doi: 10.1093.
PubMed Abstract available

STODTMANN S, Chen MJ, Siovitz L, Bereswill M, et al
Bridging Fixed Dose to Body Weight-Based Regimen of Adalimumab in Pediatric Ulcerative Colitis Using a Pharmacometric Modeling Approach: Case Study with the Phase 3 ENVISION I Trial.
J Crohns Colitis. 2022 May 8. pii: 6582407. doi: 10.1093.
PubMed Abstract available

SHRESTHA S, Brand JS, Jaras J, Schoultz I, et al
Association between inflammatory bowel disease and spondyloarthritis: findings from a nationwide study in Sweden.
J Crohns Colitis. 2022 May 5. pii: 6581445. doi: 10.1093.
PubMed Abstract available

WONG C, van Oostrom J, Bossuyt P, Pittet V, et al
A narrative systematic review and categorisation of outcomes in Inflammatory Bowel Disease to inform a Core Outcome Set for real-world evidence.
J Crohns Colitis. 2022 May 5. pii: 6580715. doi: 10.1093.
PubMed Abstract available

POULLENOT F, Amiot A, Nachury M, Viennot S, et al
Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study.
J Crohns Colitis. 2022 May 5. pii: 6580681. doi: 10.1093.
PubMed Abstract available

April 2022

DE GALAN C, Truyens M, Peeters H, Mesonero Gismero F, et al
The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients: a real-life multicentric cohort study.
J Crohns Colitis. 2022 Apr 20. pii: 6571450. doi: 10.1093.
PubMed Abstract available

FERNANDEZ ME, Nazar FN, Moine LB, Jaime CE, et al
Network analysis of inflammatory bowel disease research: towards the interactome.
J Crohns Colitis. 2022 Apr 19. pii: 6570854. doi: 10.1093.
PubMed Abstract available

UNGARO RC, Chou B, Mo J, Ursos L, et al
Impact of COVID-19 on Healthcare Resource Utilization among Patients with Inflammatory Bowel Disease in the USA.
J Crohns Colitis. 2022 Apr 9. pii: 6565722. doi: 10.1093.
PubMed Abstract available

DONG C, Chan SSM, Jantchou P, Racine A, et al
Meat intake is associated with a higher risk of ulcerative colitis in a large European prospective cohort study.
J Crohns Colitis. 2022 Apr 9. pii: 6565743. doi: 10.1093.
PubMed Abstract available

DOLINGER MT, Rolfes P, Spencer E, Stoffels G, et al
Outcomes of Children With Inflammatory Bowel Disease Who Develop Anti-Tumor Necrosis Factor Induced Skin Reactions.
J Crohns Colitis. 2022 Apr 7. pii: 6564796. doi: 10.1093.
PubMed Abstract available

HARDY PY, Fikri J, Libbrecht D, Louis E, et al
Pain characteristics in patients with inflammatory bowel disease: A monocentric cross-sectional study.
J Crohns Colitis. 2022 Apr 4. pii: 6563361. doi: 10.1093.
PubMed Abstract available

CHAPARRO M, Kunovsky L, Aguas M, Livne M, et al
Surgery Due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an Ecco Confer Multicentre Case Series (Scar Study).
J Crohns Colitis. 2022 Apr 4. pii: 6563346. doi: 10.1093.
PubMed Abstract available

COLLEN LV, Kim DY, Field M, Okoroafor I, et al
Clinical Phenotypes and Outcomes in Monogenic versus Non-Monogenic Very Early Onset Inflammatory Bowel Disease.
J Crohns Colitis. 2022 Apr 2. pii: 6562761. doi: 10.1093.
PubMed Abstract available

March 2022

CERNA K, Duricova D, Hindos M, Hindos HJ, et al
Cellular and humoral immune responses to SARS-CoV-2 vaccination in inflammatory bowel disease patients.
J Crohns Colitis. 2022 Mar 31. pii: 6561818. doi: 10.1093.
PubMed Abstract available

KHAN N, Trivedi C, Aberra F, Pernes T, et al
Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
J Crohns Colitis. 2022 Mar 29. pii: 6555677. doi: 10.1093.
PubMed Abstract available

DING NS, Tassone D, Al-Bakir I, Wu K, et al
Systematic review: The impact and importance of body composition in Inflammatory Bowel Disease.
J Crohns Colitis. 2022 Mar 24. pii: 6553364. doi: 10.1093.
PubMed Abstract available

MORTENSEN JH, Sinkeviciute D, Manon-Jensen T, Domislovic V, et al
A specific calprotectin neo-epitope (CPa9-HNE) in serum from inflammatory bowel disease patients is associated with neutrophil activity and endoscopic severity.
J Crohns Colitis. 2022 Mar 19. pii: 6550845. doi: 10.1093.
PubMed Abstract available

HYAMS JS, Turner D, Cohen SA, Szakos E, et al
Pharmacokinetics, Safety, and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn's Disease: Results from the Phase 2 HUBBLE Study.
J Crohns Colitis. 2022 Mar 17. pii: 6550285. doi: 10.1093.
PubMed Abstract available

VELOSA M, Hochner H, Yerushalmi B, Harel S, et al
Pre and perinatal factors predicting Inflammatory Bowel Disease - a population-based study with fifty years follow-up.
J Crohns Colitis. 2022 Mar 17. pii: 6550290. doi: 10.1093.
PubMed Abstract available

SANDBORN WJ, Lewis JD, Panes J, Loftus EV, et al
Association Between Proposed Definitions of Clinical Remission/Response and Well-Being in Patients With Crohn's Disease.
J Crohns Colitis. 2022;16:444-451.
PubMed Abstract available

SUAU R, Pardina E, Domenech E, Loren V, et al
The Complex Relationship Between Microbiota, Immune Response and Creeping Fat in Crohn's Disease.
J Crohns Colitis. 2022;16:472-489.
PubMed Abstract available

BLE A, Renzulli C, Cenci F, Grimaldi M, et al
The Relationship Between Endoscopic and Clinical Recurrence in Postoperative Crohn's Disease: A Systematic Review and Meta-analysis.
J Crohns Colitis. 2022;16:490-499.
PubMed Abstract available

PHILLIPS F, Verstockt B, Sladek M, de Boer N, et al
Orofacial Granulomatosis Associated with Crohn's Disease: a Multicentre Case Series.
J Crohns Colitis. 2022;16:430-435.
PubMed Abstract available

NGUYEN NH, Picetti D, Dulai PS, Jairath V, et al
Machine Learning-based Prediction Models for Diagnosis and Prognosis in Inflammatory Bowel Diseases: A Systematic Review.
J Crohns Colitis. 2022;16:398-413.
PubMed Abstract available

VIEUJEAN S, Loly JP, Boutaffala L, Meunier P, et al
Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: A Phase I-II Clinical Study.
J Crohns Colitis. 2022;16:506-510.
PubMed Abstract available

CHANCHLANI N, Lin S, Chee D, Hamilton B, et al
Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients.
J Crohns Colitis. 2022;16:389-397.
PubMed Abstract available

LEVER G, Chipeta H, Glanville T, Selinger C, et al
Perineal Outcomes After Delivery in 179 Mothers with Inflammatory Bowel Disease Compared to 31 258 Controls: A Single-Centre Cohort Study.
J Crohns Colitis. 2022;16:511-514.
PubMed Abstract available

FEAKINS R, Torres J, Borralho-Nunes P, Burisch J, et al
ECCO Topical Review on Clinicopathological Spectrum and Differential Diagnosis of Inflammatory Bowel Disease.
J Crohns Colitis. 2022;16:343-368.
PubMed Abstract available

ROBERTSON AR, Webster KL
Disease activity in the final years of life for patients with longstanding Inflammatory Bowel Disease.
J Crohns Colitis. 2022 Mar 7. pii: 6543872. doi: 10.1093.
PubMed

ABREU MT, Rowbotham DS, Danese S, Sandborn WJ, et al
Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension.
J Crohns Colitis. 2022 Mar 3. pii: 6542054. doi: 10.1093.
PubMed Abstract available

SCIBERRAS M, Karmiris K, Nascimento C, Tabone T, et al
Mental health, work presenteeism and exercise in inflammatory bowel disease.
J Crohns Colitis. 2022 Mar 3. pii: 6542057. doi: 10.1093.
PubMed Abstract available

BURGESS CJ, Schnier C, Wood R, Henderson P, et al
Prematurity, delivery method and infant feeding type are not associated with paediatric-onset inflammatory bowel disease risk: A Scottish retrospective birth cohort study.
J Crohns Colitis. 2022 Mar 1. pii: 6540489. doi: 10.1093.
PubMed Abstract available

February 2022

COTTRON C, Treton X, Altwegg R, Reenaers C, et al
How to manage inflammatory bowel disease patients when they withdraw anti-TNF due to severe anti-TNF-induced skin lesions? A multicenter cohort study.
J Crohns Colitis. 2022 Feb 26. pii: 6537448. doi: 10.1093.
PubMed Abstract available

NOWAK JK, Adams AT, Kalla R, Lindstrom JC, et al
Characterization of the circulating transcriptomic landscape in inflammatory bowel disease provides evidence for dysregulation of multiple transcription factors including NFE2, SPI1, CEBPB, and IRF2.
J Crohns Colitis. 2022 Feb 25. pii: 6536718. doi: 10.1093.
PubMed Abstract available

TRACY M, Khalili H
You Are What You Eat? Growing Evidence That Diet Influences the Risk of Inflammatory Bowel Disease.
J Crohns Colitis. 2022 Feb 23. pii: 6534662. doi: 10.1093.
PubMed

BISLENGHI G, Sucameli F, Fieuws S, Ferrante M, et al
Non-conventional Versus Conventional Strictureplasties for Crohn's Disease. A Systematic Review and Meta-analysis of Treatment Outcomes.
J Crohns Colitis. 2022;16:319-330.
PubMed Abstract available

DHALIWAL J, Carroll MW, deBruyn JC, Ricciuto A, et al
The Phenotypic Spectrum of New-onset IBD in Canadian Children of South Asian Ethnicity: A Prospective Multi-Centre Comparative Study.
J Crohns Colitis. 2022;16:216-223.
PubMed Abstract available

CLEMENT F, Nougarede A, Combe S, Kermarrec F, et al
Therapeutic siRNAs Targeting the JAK/STAT Signalling Pathway in Inflammatory Bowel Diseases.
J Crohns Colitis. 2022;16:286-300.
PubMed Abstract available

ELDRIDGE F, Raine T
Understanding and Addressing the Psychological Burden of IBD.
J Crohns Colitis. 2022;16:177-178.
PubMed

LAUDISI F, Stolfi C, Bevivino G, Maresca C, et al
GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation.
J Crohns Colitis. 2022;16:301-311.
PubMed Abstract available

BACSUR P, Farkas K, Molnar T
Area of the IBD Disk Correlated Strongly with Disease Activity Compared with the Conventionally Used IBD Disk Score.
J Crohns Colitis. 2022;16:336.
PubMed

OSTROWSKI S, Croft A
Viral enteric infections in acute severe ulcerative colitis.
J Crohns Colitis. 2022 Feb 15. pii: 6528523. doi: 10.1093.
PubMed Abstract available

CROFT A, Lord A, Radford-Smith G
Markers of systemic inflammation in acute attacks of ulcerative colitis: What level of C-reactive protein constitutes severe colitis?
J Crohns Colitis. 2022 Feb 11. pii: 6527048. doi: 10.1093.
PubMed Abstract available

MOOKHOEK A, Haasnoot ML, Bredenoord AJ, Ma C, et al
The clinical significance of eosinophils in ulcerative colitis: a systematic review.
J Crohns Colitis. 2022 Feb 9. pii: 6524727. doi: 10.1093.
PubMed Abstract available

HUA X, Lopes EW, Burke KE, Ananthakrishnan AN, et al
Smoking behavior changes after diagnosis of inflammatory bowel disease and risk of all-cause mortality.
J Crohns Colitis. 2022 Feb 1. pii: 6518234. doi: 10.1093.
PubMed Abstract available

January 2022

VERMEIRE S, D'Haens G, Baert F, Danese S, et al
Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial.
J Crohns Colitis. 2022;16:27-38.
PubMed Abstract available

ALBSHESH A, Eder P, Ribaldone DG, Oldenburg B, et al
Primary Hypogammaglobulinaemia with Inflammatory Bowel Disease-Like Features: An ECCO CONFER Multicentre Case Series.
J Crohns Colitis. 2022;16:91-97.
PubMed Abstract available

ZILBAUER M, Heuschkel R
Disease Prognostic Biomarkers in Inflammatory Bowel Diseases-A Reality Check.
J Crohns Colitis. 2022;16:162-165.
PubMed Abstract available

FERREIRA JPS, de Mascarenhas Saraiva MJDQEC, Afonso JPL, Ribeiro TFC, et al
Identification of Ulcers and Erosions by the Novel Pillcam Crohn's Capsule Using a Convolutional Neural Network: A Multicentre Pilot Study.
J Crohns Colitis. 2022;16:169-172.
PubMed Abstract available

HELWIG U, Fischer I, Hammer L, Kolterer S, et al
Transmural Response and Transmural Healing Defined by Intestinal Ultrasound: New Potential Therapeutic Targets?
J Crohns Colitis. 2022;16:57-67.
PubMed Abstract available

KABIR M, Thomas-Gibson S, Hart AL, Wilson A, et al
Perception of Cancer Risk and Management Practice for Colitis-associated Dysplasia Is Influenced by Colonoscopy Experience and Workplace Affiliation: Results of an International Clinician Survey.
J Crohns Colitis. 2022;16:39-48.
PubMed Abstract available

FULFORTH J, Gearry R
Inequitable Access to IBD Therapies Extends Beyond Developing Nations.
J Crohns Colitis. 2022;16:173-174.
PubMed

HANZEL J, Jairath V
A TIGER Among Endoscopic Indices in Inflammatory Bowel Disease.
J Crohns Colitis. 2022 Jan 21. pii: 6513472. doi: 10.1093.
PubMed

NUNEZ F P, Quera R, Bay C, Castro F, et al
Drug-induced liver injury used in the treatment of Inflammatory Bowel Disease.
J Crohns Colitis. 2022 Jan 19. pii: 6511546. doi: 10.1093.
PubMed Abstract available

ELLUL P, Reves J, Abreu B, Chaparro M, et al
Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey.
J Crohns Colitis. 2022 Jan 17. pii: 6509060. doi: 10.1093.
PubMed Abstract available

JUZENAS S, Hubenthal M, Lindqvist CM, Kruse R, et al
Detailed transcriptional landscape of peripheral blood points to increased neutrophil activation in treatment-naive inflammatory bowel disease.
J Crohns Colitis. 2022 Jan 11. pii: 6503823. doi: 10.1093.
PubMed Abstract available

DE BOER NK, van Lookeren FL, Tack GJ
The launch of an online national multidisciplinary expert panel for inflammatory bowel disease.
J Crohns Colitis. 2022 Jan 6. pii: 6499222. doi: 10.1093.
PubMed

HERNANDEZ-ROCHA C, Nayeri S, Turpin W, Steel M, et al
Combined histo-endoscopic remission but not endoscopic healing alone in ulcerative colitis is associated with a mucosal transcriptional profile resembling healthy mucosa.
J Crohns Colitis. 2022 Jan 6. pii: 6499459. doi: 10.1093.
PubMed Abstract available

TORRENTE F, Hansen R
Venous Thromboembolism in Children with Inflammatory Bowel Disease: When is the Right Time for Thromboprophylaxis?
J Crohns Colitis. 2022 Jan 3. pii: 6494523. doi: 10.1093.
PubMed

December 2021

VENTRESS E, Young D, Rahmany S, Harris C, et al
Transitioning from intRavenous to subcutAneous VEdolizumab in patients with infLammatory bowEl diSeaSe (TRAVELESS).
J Crohns Colitis. 2021 Dec 22. pii: 6478741. doi: 10.1093.
PubMed Abstract available

GIANNINI EG, Demarzo MG, Bodini G
Elevated Adherence to Vaccination Against SARS-CoV-2 Among Patients with Inflammatory Bowel Disease.
J Crohns Colitis. 2021;15:2142-2143.
PubMed

GOLDBERG R, Clough JN, Roberts LB, Sanchez J, et al
A Crohn's Disease-associated IL2RA Enhancer Variant Determines the Balance of T Cell Immunity by Regulating Responsiveness to IL-2 Signalling.
J Crohns Colitis. 2021;15:2054-2065.
PubMed Abstract available

RYVCHIN R, Dubinsky V, Rabinowitz K, Wasserberg N, et al
Alteration in Urease-producing Bacteria in the Gut Microbiomes of Patients with Inflammatory Bowel Diseases.
J Crohns Colitis. 2021;15:2066-2077.
PubMed Abstract available

SPALINGER MR, Schwarzfischer M, Niechcial A, Atrott K, et al
Loss of PTPN22 Promotes Intestinal Inflammation by Compromising Granulocyte-mediated Antibacterial Defence.
J Crohns Colitis. 2021;15:2118-2130.
PubMed Abstract available

DERIKX LAAP, Dolby HW, Plevris N, Lucaciu L, et al
Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naive SB5 Observational Cohorts.
J Crohns Colitis. 2021;15:2011-2021.
PubMed Abstract available

FERRANTE M, Feagan BG, Panes J, Baert F, et al
Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study.
J Crohns Colitis. 2021;15:2001-2010.
PubMed Abstract available

NI H, Chen Y, Xia W, Wang C, et al
SATB2 Defect Promotes Colitis and Colitis-associated Colorectal Cancer by Impairing Cl-/HCO3- Exchange and Homeostasis of Gut Microbiota.
J Crohns Colitis. 2021;15:2088-2102.
PubMed Abstract available

WANG L, Zhang N, Han D, Su P, et al
MTDH Promotes Intestinal Inflammation by Positively Regulating TLR Signalling.
J Crohns Colitis. 2021;15:2103-2117.
PubMed Abstract available

CASADO-BEDMAR M, Viennois E
microRNA and gut microbiota: Tiny but mighty - Novel insights of their crosstalk in inflammatory bowel disease pathogenesis and therapeutics.
J Crohns Colitis. 2021 Dec 16. pii: 6464304. doi: 10.1093.
PubMed Abstract available

CALAFAT M, Manosa M, Ricart E, Nos P, et al
Risk of immunomediated adverse events and loss of response to infliximab in elderly patients with inflammatory bowel disease. A cohort study of the ENEIDA registry.
J Crohns Colitis. 2021 Dec 3. pii: 6448705. doi: 10.1093.
PubMed Abstract available

FESTA S, Zerboni G, Derikx LAAP, Ribaldone DG, et al
Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.
J Crohns Colitis. 2021 Dec 1. pii: 6447455. doi: 10.1093.
PubMed Abstract available

November 2021

GORDON IO, Abushamma S, Kurowski JA, Holubar SD, et al
Pediatric Ulcerative Colitis Is A Fibrotic Disease And Linked With Chronicity Of Inflammation.
J Crohns Colitis. 2021 Nov 29. pii: 6445941. doi: 10.1093.
PubMed Abstract available

BAR-YOSEPH H, Blatt A, Gerassy S, Pressman S, et al
Differential serum-intestinal dynamics of infliximab and adalimumab in inflammatory bowel disease patients.
J Crohns Colitis. 2021 Nov 24. pii: 6438514. doi: 10.1093.
PubMed Abstract available

PRENTICE RE, Ross AL, Flanagan EK
Management of Pregnant Women with Inflammatory Bowel Disease and COVID-19-Balancing Risks of Delayed Treatment Recommencement.
J Crohns Colitis. 2021 Nov 23. pii: 6433604. doi: 10.1093.
PubMed

PAPAEFTHYMIOU A, Potamianos S, Goulas A, Doulberis M, et al
Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents.
J Crohns Colitis. 2021 Nov 22. pii: 6433262. doi: 10.1093.
PubMed Abstract available

ATIA O, Orlanski-Meyer E, Lujan R, Ledderman N, et al
Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN.
J Crohns Colitis. 2021 Nov 20. pii: 6432553. doi: 10.1093.
PubMed Abstract available

BACSUR P, Farkas K, Molnar T
Outcome of immediate dose optimization of infliximab in inflammatory bowel disease patients.
J Crohns Colitis. 2021 Nov 18. pii: 6430840. doi: 10.1093.
PubMed

GUPTA R, MacIsaac M, Wright EK
Sleeve gastrectomy in patients with inflammatory bowel disease is not associated with worsening disease.
J Crohns Colitis. 2021 Nov 17. pii: 6430439. doi: 10.1093.
PubMed

D'AMICO F, Magro F, Peyrin-Biroulet L, Danese S, et al
Positioning filgotinib in the treatment algorithm of moderate to severe ulcerative colitis.
J Crohns Colitis. 2021 Nov 16. pii: 6429427. doi: 10.1093.
PubMed Abstract available

NICHOLSON MR, Alexander E, Ballal S, Davidovics Z, et al
Efficacy and Outcomes of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease.
J Crohns Colitis. 2021 Nov 12. pii: 6425925. doi: 10.1093.
PubMed Abstract available

VAN ERP LW, Neijenhuis MK, Heida W, Derwig J, et al
Improving care for recently diagnosed inflammatory bowel disease patients: Lessons learned from a patient-centred, mixed-method study.
J Crohns Colitis. 2021 Nov 10. pii: 6425110. doi: 10.1093.
PubMed Abstract available

CHARPY F, Altwegg R, Debourdeau A
Disseminated tuberculosis in a patient treated with tofacitinib for ulcerative colitis.
J Crohns Colitis. 2021 Nov 9. pii: 6424411. doi: 10.1093.
PubMed

AGRAWAL M, Zhang X, Brenner EJ, Ungaro RC, et al
The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry.
J Crohns Colitis. 2021;15:1877-1884.
PubMed Abstract available

WETWITTAYAKHLANG P, Lakatos PL
Comforting Data on the Incidence of Rectal Cancer After Subtotal Colectomy in IBD: The Risk Is Low, Yet Surveillance Matters!
J Crohns Colitis. 2021;15:1783-1784.
PubMed

ROSH JR, Turner D, Griffiths A, Cohen SA, et al
Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn's Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 Study.
J Crohns Colitis. 2021;15:1931-1942.
PubMed Abstract available

REZAZADEH ARDABILI A, Goudkade D, Wintjens D, Romberg-Camps M, et al
Histopathological Features in Colonic Biopsies at Diagnosis Predict Long-term Disease Course in Patients with Crohn's Disease.
J Crohns Colitis. 2021;15:1885-1897.
PubMed Abstract available

SELIN KA, Hedin CRH, Villablanca EJ
Immunological Networks Defining the Heterogeneity of Inflammatory Bowel Diseases.
J Crohns Colitis. 2021;15:1959-1973.
PubMed Abstract available

NAFTALI T, Bar-Lev Schleider L, Almog S, Meiri D, et al
Oral CBD-rich Cannabis Induces Clinical but Not Endoscopic Response in Patients with Crohn's Disease, a Randomised Controlled Trial.
J Crohns Colitis. 2021;15:1799-1806.
PubMed Abstract available

LUO J, Xu Z, Noordam R, van Heemst D, et al
Depression and Inflammatory Bowel Disease: A Bidirectional two-sample Mendelian Randomization Study.
J Crohns Colitis. 2021 Nov 5. pii: 6421452. doi: 10.1093.
PubMed Abstract available

October 2021

GARRIDO I, Lopes S, Macedo G
"Safety of COVID-19 vaccination in inflammatory bowel disease patients on biologic therapy".
J Crohns Colitis. 2021 Oct 30. pii: 6414658. doi: 10.1093.
PubMed

LIMA SF, Longman RS
Eating for Two: Diet and the Microbiome in Ulcerative Colitis.
J Crohns Colitis. 2021 Oct 27. pii: 6412629. doi: 10.1093.
PubMed

FRIEDMAN S, Zegers FD, Jolving LR, Nielsen J, et al
Postpartum surgical complications in women with inflammatory bowel disease after caesarian section: A Danish nationwide cohort study.
J Crohns Colitis. 2021 Oct 27. pii: 6412778. doi: 10.1093.
PubMed Abstract available

CHARKAOUI M, Hajage D, Tubach F, Laurent B, et al
Impact of anti-tumor necrosis factor agents on the risk of colorectal cancer in patients with ulcerative colitis: nationwide French cohort study.
J Crohns Colitis. 2021 Oct 18. pii: 6399096. doi: 10.1093.
PubMed Abstract available

RAINE T, Bonovas S, Burisch J, Kucharzik T, et al
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.
J Crohns Colitis. 2021 Oct 12. pii: 6390052. doi: 10.1093.
PubMed

SPINELLI A, Bonovas S, Burisch J, Kucharzik T, et al
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.
J Crohns Colitis. 2021 Oct 12. pii: 6390023. doi: 10.1093.
PubMed Abstract available

ELFIKY AMI, Ghiboub M, Li Yim AYF, Hageman IL, et al
Carboxylesterase-1 assisted targeting of HDAC inhibitors to mononuclear myeloid cells in Inflammatory Bowel Disease.
J Crohns Colitis. 2021 Oct 11. pii: 6387695. doi: 10.1093.
PubMed Abstract available

WALENTYNOWICZ M, van de Pavert I, Fierens L, Coenen S, et al
Inflammatory Bowel Disease-related Behaviours [IBD-Bx] questionnaire: Development, validation, and prospective associations with fatigue.
J Crohns Colitis. 2021 Oct 8. pii: 6383644. doi: 10.1093.
PubMed Abstract available

JOJART B, Molnar T, Szabo V, Varga A, et al
Erratum to: P459 Expression of SerpinE1, a potential new disease activity marker, reflects therapeutic response in Inflammatory Bowel Disease.
J Crohns Colitis. 2021 Oct 7. pii: 6383122. doi: 10.1093.
PubMed

ADAMINA M, Fiorino G
At the Crossroads of Caution and Intervention: Anti-TNF Therapy Prior to Elective CD Surgery.
J Crohns Colitis. 2021;15:1778-1779.
PubMed

MEKORI-DOMACHEVSKY E, Ben-Horin S
Holistic approach to IBD patients.
J Crohns Colitis. 2021;15:1782.
PubMed

SOOP M, Hancock L, Davies J
Anti-TNF Therapy Before Intestinal Surgery for Crohn's Disease and the Risks of Postoperative Complications.
J Crohns Colitis. 2021;15:1777.
PubMed

HONAP S, Irving PM, Kennedy NA
Response to 'Clinical Efficacy of Tofacitinib in Moderate to Severe Ulcerative Colitis'.
J Crohns Colitis. 2021;15:1775-1776.
PubMed

RAINE T, Verstockt B, Kopylov U, Karmiris K, et al
ECCO Topical Review: Refractory Inflammatory Bowel Disease.
J Crohns Colitis. 2021;15:1605-1620.
PubMed Abstract available

UNGAR B, Malickova K, Hanzel J, Abu Arisha M, et al
Dose optimisation for Loss of Response to Vedolizumab- Pharmacokinetics and Immune Mechanisms.
J Crohns Colitis. 2021;15:1707-1719.
PubMed Abstract available

VIEUJEAN S, Hu S, Bequet E, Salee C, et al
Potential Role of Epithelial Endoplasmic Reticulum Stress and Anterior Gradient Protein 2 Homologue in Crohn's Disease Fibrosis.
J Crohns Colitis. 2021;15:1737-1750.
PubMed Abstract available

NARULA N, Wong ECL, Dulai PS, Marshall JK, et al
Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn's Disease: A Post-hoc Analysis.
J Crohns Colitis. 2021;15:1649-1657.
PubMed Abstract available

ILVEMARK JFKF, Hansen T, Goodsall TM, Seidelin JB, et al
Defining transabdominal Intestinal Ultrasound treatment response and remission in Inflammatory Bowel Disease: Systematic review and expert consensus statement.
J Crohns Colitis. 2021 Oct 6. pii: 6382324. doi: 10.1093.
PubMed Abstract available

AARDOOM MA, Klomberg RCW, Kemos P, Ruemmele FM, et al
The incidence and characteristics of venous thromboembolisms in paediatric-onset inflammatory bowel disease; a prospective international cohort study based on the PIBD-SETQuality Safety Registry.
J Crohns Colitis. 2021 Oct 2. pii: 6380289. doi: 10.1093.
PubMed Abstract available

September 2021

RICCIUTO A, Lamb CA, Benchimol EI, Walker GJ, et al
Inflammatory Bowel Disease Clinical Activity Is Associated with COVID-19 Severity Especially in Younger Patients.
J Crohns Colitis. 2021 Sep 27. pii: 6376474. doi: 10.1093.
PubMed Abstract available

DART RJ, Ellul P, Scharl M, Lamb CA, et al
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD - Challenges and Future Directions.
J Crohns Colitis. 2021;15:1407-1409.
PubMed

FIOCCHI C, Dragoni G, Iliopoulos D, Katsanos K, et al
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-What, Why, and How.
J Crohns Colitis. 2021;15:1410-1430.
PubMed Abstract available

VERSTOCKT B, Noor NM, Marigorta UM, Pavlidis P, et al
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to Therapy.
J Crohns Colitis. 2021;15:1431-1442.
PubMed Abstract available

LI Y, Zhu L, Chen P, Wang Y, et al
MALAT1 Maintains the Intestinal Mucosal Homeostasis in Crohn's Disease via the miR-146b-5p-CLDN11/NUMB Pathway.
J Crohns Colitis. 2021;15:1542-1557.
PubMed Abstract available

DE KRIJGER M, Wildenberg ME, Mookhoek A, Verheul S, et al
Expression of MAdCAM-1 and Gut-homing T Cells in Inflamed Pouch Mucosa.
J Crohns Colitis. 2021;15:1491-1499.
PubMed Abstract available

RUSSO E, Giudici F, Ricci F, Scaringi S, et al
Diving into Inflammation: A Pilot Study Exploring the Dynamics of the Immune-Microbiota Axis in Ileal Tissue Layers of Patients with Crohn's Disease.
J Crohns Colitis. 2021;15:1500-1516.
PubMed Abstract available

SOLA TAPIAS N, Denadai-Souza A, Rolland-Fourcade C, Quaranta-Nicaise M, et al
Colitis Linked to Endoplasmic Reticulum Stress Induces Trypsin Activity Affecting Epithelial Functions.
J Crohns Colitis. 2021;15:1528-1541.
PubMed Abstract available

CHEN D, Fulmer C, Gordon IO, Syed S, et al
Application of Artificial Intelligence to Clinical Practice in Inflammatory Bowel Disease - What the Clinician Needs to Know.
J Crohns Colitis. 2021 Sep 24. pii: 6374854. doi: 10.1093.
PubMed Abstract available

WONG D, Travis SPL
Patient-reported Goals in Inflammatory Bowel Disease: What's the Problem?
J Crohns Colitis. 2021 Sep 21. pii: 6373333. doi: 10.1093.
PubMed

SARBAGILI SHABAT C, Scaldaferri F, Zittan E, Hirsch A, et al
Use of Fecal transplantation with a novel diet for mild to moderate active ulcerative colitis: The CRAFT UC randomized controlled trial.
J Crohns Colitis. 2021 Sep 13. pii: 6369227. doi: 10.1093.
PubMed Abstract available

PHILLIPS F, Verstockt B, Ribaldone DG, Guerra I, et al
Diagnosis and outcome of extranodal primary intestinal lymphoma in inflammatory bowel disease: an ECCO CONFER case series.
J Crohns Colitis. 2021 Sep 11. pii: 6368841. doi: 10.1093.
PubMed Abstract available

KIM GH, Lee YC, Kim TJ, Kim ER, et al
Risk of neurodegenerative diseases in patients with inflammatory bowel disease: a nationwide population-based cohort study.
J Crohns Colitis. 2021 Sep 9. pii: 6367800. doi: 10.1093.
PubMed Abstract available

BOURGONJE AR, Hu S, Spekhorst LM, Zhernakova DV, et al
The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease.
J Crohns Colitis. 2021 Sep 7. pii: 6365883. doi: 10.1093.
PubMed Abstract available

August 2021

BOTS S, Nylund K, Gecse K
Response to letter to the editor "Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound index".
J Crohns Colitis. 2021 Aug 14. pii: 6352305. doi: 10.1093.
PubMed

CARON B, D'Amico F, Danese S, Peyrin-Biroulet L, et al
Cluster Randomized Trials: Lessons for Inflammatory Bowel Disease Trials.
J Crohns Colitis. 2021 Aug 14. pii: 6352195. doi: 10.1093.
PubMed Abstract available

REUKEN PA, Andreas N, Grunert PC, Glockner S, et al
T cell response after SARS-CoV-2 vaccination in immunocompromised patients with inflammatory bowel disease.
J Crohns Colitis. 2021 Aug 11. pii: 6348138. doi: 10.1093.
PubMed Abstract available

CROWLEY E, Ma C, Andic M, Feagan BG, et al
Impact of Drug Approval Pathways for Paediatric Inflammatory Bowel Disease.
J Crohns Colitis. 2021 Aug 11. pii: 6348023. doi: 10.1093.
PubMed Abstract available

TSE CS, Van Citters AD, Ricci B, Freundlich NZ, et al
Identifying and Predicting the Goals and Concerns Prioritized by Individuals with Inflammatory Bowel Disease.
J Crohns Colitis. 2021 Aug 5. pii: 6341120. doi: 10.1093.
PubMed Abstract available

CARVELLO M, Bellato V, Maroli A, Hart A, et al
A multidisciplinary approach to rectal cancer treatment in ulcerative colitis results in high rate of restorative minimally invasive surgery.
J Crohns Colitis. 2021 Aug 4. pii: 6338719. doi: 10.1093.
PubMed Abstract available

PROIETTI E, Fuhler GM, Peppelenbosch MP
Mycobacterium Avium Subspecies Paratuberculosis Infection and Biological Treatment of IBD: Cause or Consequence?
J Crohns Colitis. 2021;15:1247-1249.
PubMed

WELLENS J, Colombel JF, Satsangi JJ, Wong SY, et al
SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future Challenges.
J Crohns Colitis. 2021;15:1376-1386.
PubMed Abstract available

LOCHHEAD P, Khalili H, Sachs MC, Chan AT, et al
Statin Use and Risk of Inflammatory Bowel Diseases: Authors' Reply.
J Crohns Colitis. 2021;15:1403-1404.
PubMed

TURSI A, Mocci G, Maconi G
Effect of Ustekinumab on Extraintestinal Diseases in Refractory Crohn's Disease.
J Crohns Colitis. 2021;15:1399-1400.
PubMed

CARON B, D'Amico F, Danese S, Peyrin-Biroulet L, et al
Endpoints for Perianal Crohn's Disease Trials: Past, Present and Future.
J Crohns Colitis. 2021;15:1387-1398.
PubMed Abstract available

ELLRICHMANN M, Bethge J, Boesenkoetter J, Conrad C, et al
Subclinical Pulmonary Involvement in Active IBD Responds to Biologic Therapy.
J Crohns Colitis. 2021;15:1339-1345.
PubMed Abstract available

CAER C, Gorreja F, Forsskahl SK, Brynjolfsson SF, et al
TREM-1+ Macrophages Define a Pathogenic Cell Subset in the Intestine of Crohn's Disease Patients.
J Crohns Colitis. 2021;15:1346-1361.
PubMed Abstract available

CAMBI MPC, Yamamoto T, Kotze PG
Importance of Nutrition and Hypoalbuminaemia in Postoperative Morbidity in Crohn's Disease: Thinking Outside of the Box on Biologics as Single Risk Factors.
J Crohns Colitis. 2021;15:1401-1402.
PubMed

CHANG I, Park S, Lee HJ, Kim I, et al
Interpretation of XIAP Variants of Uncertain Significance in Paediatric Patients with Refractory Crohn's Disease.
J Crohns Colitis. 2021;15:1291-1304.
PubMed Abstract available

PETERS V, Spooren CEGM, Pierik MJ, Weersma RK, et al
Dietary Intake Pattern is Associated with Occurrence of Flares in IBD Patients.
J Crohns Colitis. 2021;15:1305-1315.
PubMed Abstract available

July 2021

SEDANO R, Hogan M, Nguyen TM, Chang J, et al
Systematic review and Meta-analysis: Clinical, Endoscopic, Histologic and Safety Placebo Rates in Induction and Maintenance trials of Ulcerative Colitis.
J Crohns Colitis. 2021 Jul 26. pii: 6328606. doi: 10.1093.
PubMed Abstract available

PARK SH, Im JP, Park H, Jeong SK, et al
Clinical features and long-term outcomes of pediatric-onset inflammatory bowel disease in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea.
J Crohns Colitis. 2021 Jul 26. pii: 6328476. doi: 10.1093.
PubMed Abstract available

BOSSUYT P, Pouillon L, Claeys S, D'Haens S, et al
Ultra-proactive therapeutic drug monitoring of infliximab based on point-of-care-testing in inflammatory bowel disease: results of a pragmatic trial.
J Crohns Colitis. 2021 Jul 23. pii: 6326544. doi: 10.1093.
PubMed Abstract available

CHEE D, Nice R, Hamilton B, Jones E, et al
Patient-led Remote IntraCapillary pharmacoKinetic Sampling (fingerPRICKS) for therapeutic drug monitoring in patients with inflammatory bowel disease.
J Crohns Colitis. 2021 Jul 21. pii: 6325142. doi: 10.1093.
PubMed Abstract available

DIEZ-OBRERO V, Moratalla-Navarro F, Ibanez-Sanz G, Guardiola J, et al
Transcriptome-wide association study for inflammatory bowel disease reveals novel candidate susceptibility genes in specific colon subsites and tissue categories.
J Crohns Colitis. 2021 Jul 21. pii: 6324884. doi: 10.1093.
PubMed Abstract available

ZITTAN E, Steinhart AH, Aran H, Milgrom R, et al
The Toronto Ibd Global Endoscopic Reporting (Tiger) Score: A Single, Easy To Use Endoscopic Score For Both Crohn's Disease And Ulcerative Colitis Patients.
J Crohns Colitis. 2021 Jul 17. pii: 6323260. doi: 10.1093.
PubMed Abstract available

DINALLO V, Di Fusco D, Di Grazia A, Laudisi F, et al
The deubiquitinating enzyme OTUD5 sustains inflammatory cytokine response in inflammatory bowel disease.
J Crohns Colitis. 2021 Jul 7. pii: 6316763. doi: 10.1093.
PubMed Abstract available

CHOI WT, Salomao M, Zhao L, Alpert L, et al
Hypermucinous, Goblet Cell Deficient, and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
J Crohns Colitis. 2021 Jul 7. pii: 6316756. doi: 10.1093.
PubMed Abstract available

DELISLE M, Wilkens R, Novak KL
Keeping It Simple: Using Intestinal Ultrasound to Assess Ulcerative Colitis with a Novel UC-Ultrasound Index.
J Crohns Colitis. 2021 Jul 5. pii: 6315708. doi: 10.1093.
PubMed

RESTELLINI S, Lakatos PL
Patient-Reported Outcomes in Inflammatory Bowel Diseases: Another Piece in the Puzzle.
J Crohns Colitis. 2021;15:1085-1086.
PubMed

GUPTA V, Mohsen W, Chapman TP, Satsangi J, et al
Predicting Outcome in Acute Severe Colitis-Controversies in Clinical Practice in 2021.
J Crohns Colitis. 2021;15:1211-1221.
PubMed Abstract available

DAI C, Jiang M, Huang YH
Association Between Statin Use and Inflammatory Bowel Diseases.
J Crohns Colitis. 2021;15:1246.
PubMed

ADAMINA M, Feakins R, Iacucci M, Spinelli A, et al
ECCO Topical Review Optimising Reporting in Surgery, Endoscopy, and Histopathology.
J Crohns Colitis. 2021;15:1089-1105.
PubMed Abstract available

XU M, Shen Y, Cen M, Zhu Y, et al
Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice.
J Crohns Colitis. 2021;15:1197-1210.
PubMed Abstract available

LI XH, Feng ST, Cao QH, Coffey JC, et al
Degree of Creeping Fat Assessed by Computed Tomography Enterography is Associated with Intestinal Fibrotic Stricture in Patients with Crohn's Disease: A Potentially Novel Mesenteric Creeping Fat Index.
J Crohns Colitis. 2021;15:1161-1173.
PubMed Abstract available

KIM PH, Kim SH, Cho YA, Yoon HM, et al
Ability of Pelvic Magnetic Resonance Imaging to Predict Clinical Course of Perianal Fistula in Paediatric Crohn's Disease Patients.
J Crohns Colitis. 2021;15:1152-1160.
PubMed Abstract available

SHAH RS, Bachour S, Jia X, Holubar SD, et al
Hypoalbuminaemia, Not Biologic Exposure, Is Associated with Postoperative Complications in Crohn's Disease Patients Undergoing Ileocolic Resection.
J Crohns Colitis. 2021;15:1142-1151.
PubMed Abstract available

POLETTI M, Arnauts K, Ferrante M, Korcsmaros T, et al
Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD.
J Crohns Colitis. 2021;15:1222-1235.
PubMed Abstract available

WONG ECL, Buffone E, Lee SJ, Dulai PS, et al
End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn's Disease.
J Crohns Colitis. 2021;15:1114-1119.
PubMed Abstract available

COX SR, Clarke H, O'Keeffe M, Dubois P, et al
Nutrient, fibre and FODMAP intakes and food-related quality of life in patients with inflammatory bowel disease and their relationship with gastrointestinal symptoms of differing aetiologies.
J Crohns Colitis. 2021 Jul 3. pii: 6314229. doi: 10.1093.
PubMed Abstract available

June 2021

WATANABE S, Hibiya S, Katsukura N, Kitagawa S, et al
Importance of telomere shortening in the pathogenesis of ulcerative colitis: A new treatment from the aspect of telomeres in intestinal epithelial cells.
J Crohns Colitis. 2021 Jun 28. pii: 6310549. doi: 10.1093.
PubMed Abstract available

GUBATAN J, Rubin SJS, Bai L, Haileselassie Y, et al
Vitamin D is Associated with alpha4beta7+ Immunophenotypes and Predicts Vedolizumab Therapy Failure in Patients with Inflammatory Bowel Disease.
J Crohns Colitis. 2021 Jun 28. pii: 6310486. doi: 10.1093.
PubMed Abstract available

KUENZIG ME, Bitton A, Carroll MW, Kaplan GG, et al
Inflammatory bowel disease increases the risk of venous thromboembolism in children: a population-based matched cohort study.
J Crohns Colitis. 2021 Jun 27. pii: 6310166. doi: 10.1093.
PubMed Abstract available

KIM PH, Yoon HM, Jung AY, Lee JS, et al
Diagnostic Performance of Diffusion-weighted Imaging for Evaluation of Bowel Inflammation in Pediatric Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
J Crohns Colitis. 2021 Jun 22. pii: 6308099. doi: 10.1093.
PubMed Abstract available

GILMORE R, Hilley P, Srinivasan A, Choy M, et al
Sequential use of high-dose tofacitinib after infliximab salvage therapy in acute severe ulcerative colitis.
J Crohns Colitis. 2021 Jun 22. pii: 6308093. doi: 10.1093.
PubMed Abstract available

ABAKKOUY Y, Cleynen I
The Promise of Polygenic Risk Scores as a Research Tool to Analyse the Genetics Underlying IBD Phenotypes.
J Crohns Colitis. 2021;15:877-878.
PubMed

ATTAUABI M, Seidelin JB, Burisch J
Authors' Reply to: 'COVID-19 in the IBD Population: The Need for Correct Nomenclature'.
J Crohns Colitis. 2021;15:1080.
PubMed

STOCKER D, King MJ, El Homsi M, Carbonell G, et al
Luminal Narrowing Alone Allows an Accurate Diagnosis of Crohn's Disease Small Bowel Strictures at Cross-Sectional Imaging.
J Crohns Colitis. 2021;15:1009-1018.
PubMed Abstract available

BUISSON A, Filippi J, Amiot A, Cadiot G, et al
Defining and Assessing the Reproducibility of Crohn's Disease Endoscopic Lesions: A Delphi-like Method from the GETAID.
J Crohns Colitis. 2021;15:1000-1008.
PubMed Abstract available

SYAL G, Shemtov R, Bonthala N, Vasiliauskas EA, et al
Pre-pouch Ileitis is Associated with Development of Crohn's Disease-like Complications and Pouch Failure.
J Crohns Colitis. 2021;15:960-968.
PubMed Abstract available

GIANOTTI RJ, Cheifetz AS
Cannabis and Inflammatory Bowel Disease: All Smoke and Mirrors?
J Crohns Colitis. 2021 Jun 17. pii: 6301791. doi: 10.1093.
PubMed

JOHNSON AM, Harmsen WS, Aniwan S, Tremaine WJ, et al
Prevalence and Impact of Obesity on Disease-Specific Outcomes in a Population-Based Cohort of Patients with Ulcerative Colitis.
J Crohns Colitis. 2021 Jun 12. pii: 6297429. doi: 10.1093.
PubMed Abstract available

PORTER RJ, Arends MJ, Churchhouse AMD, Din S, et al
Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines.
J Crohns Colitis. 2021 Jun 10. pii: 6295922. doi: 10.1093.
PubMed Abstract available

GHOSH S, Sanchez Gonzalez Y, Zhou W, Clark R, et al
Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative Colitis.
J Crohns Colitis. 2021 Jun 9. pii: 6295522. doi: 10.1093.
PubMed Abstract available

HERNANDEZ-ROCHA C, Borowski K, Turpin W, Filice M, et al
Integrative analysis of colonic biopsies from inflammatory bowel disease patients identifies an interaction between microbial bile-acid inducible gene abundance and human Angiopoietin-like 4 gene expression.
J Crohns Colitis. 2021 Jun 2. pii: 6291049. doi: 10.1093.
PubMed Abstract available

May 2021

FUMERY M, Chatelain D
Histological Scores in Inflammatory Bowel Disease: A New Kid in the Block.
J Crohns Colitis. 2021 May 27. pii: 6286012. doi: 10.1093.
PubMed

DHERI AK, Kuenzig ME, Mack DR, Murthy SK, et al
Shifting health care use from hospitalizations and surgeries to outpatient visits in children with inflammatory bowel disease: a population-based cohort study from Ontario, Canada.
J Crohns Colitis. 2021 May 21. pii: 6279878. doi: 10.1093.
PubMed Abstract available

WEISSMAN S, Patel K, Kolli S, Lipcsey M, et al
Obesity in Inflammatory Bowel Disease is Associated with Early Readmissions characterized by an Increased Systems and Patient-level Burden.
J Crohns Colitis. 2021 May 17. pii: 6276891. doi: 10.1093.
PubMed Abstract available

REZAZADEH ARDABILI A, Creemers RH, van Bodegraven AA
COVID-19 in the IBD Population: The Need for Correct Nomenclature.
J Crohns Colitis. 2021;15:872-873.
PubMed

BERTE' R, Mazza S, Stefanucci MR, Noviello D, et al
Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy.
J Crohns Colitis. 2021;15:864-868.
PubMed Abstract available

REZAZADEH ARDABILI A, Hendrix EMB, Pierik MJ
Remote Monitoring of Inflammatory Bowel Disease: What Kind of Patient-Reported Questionnaires Should We Use?
J Crohns Colitis. 2021;15:869-870.
PubMed

CROSBY S, Schuh MJ, Farraye FA
Rechallenge with Subcutaneous Ustekinumab After Hypersensitivity Reaction to Intravenous Ustekinumab.
J Crohns Colitis. 2021;15:871.
PubMed

ASHTON JJ, Boukas K, Davies J, Stafford IS, et al
Ileal Transcriptomic Analysis in Paediatric Crohn's Disease Reveals IL17- and NOD-signalling Expression Signatures in Treatment-naive Patients and Identifies Epithelial Cells Driving Differentially Expressed Genes.
J Crohns Colitis. 2021;15:774-786.
PubMed Abstract available

LOCHHEAD P, Khalili H, Sachs MC, Chan AT, et al
Association Between Statin Use and Inflammatory Bowel Diseases: Results from a Swedish, Nationwide, Population-based Case-control Study.
J Crohns Colitis. 2021;15:757-765.
PubMed Abstract available

KLANG E, Grinman A, Soffer S, Margalit Yehuda R, et al
Automated Detection of Crohn's Disease Intestinal Strictures on Capsule Endoscopy Images Using Deep Neural Networks.
J Crohns Colitis. 2021;15:749-756.
PubMed Abstract available

MOTTA JP, Palese S, Giorgio C, Chapman K, et al
Increased Mucosal Thrombin is Associated with Crohn's Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation.
J Crohns Colitis. 2021;15:787-799.
PubMed Abstract available

NELSON A, Stewart CJ, Kennedy NA, Lodge JK, et al
The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn's Disease Patients in Remission and in Individuals Without Gastrointestinal Inflammation.
J Crohns Colitis. 2021;15:800-812.
PubMed Abstract available

MULLER M, D'Amico F, Bonovas S, Danese S, et al
TNF Inhibitors and Risk of Malignancy in Patients with Inflammatory Bowel Diseases: A Systematic Review.
J Crohns Colitis. 2021;15:840-859.
PubMed Abstract available

April 2021

VAN ERP LW, van Gerven J, Bloem S, Groenen MJM, et al
Acceptance and perceived control are independently associated with quality of life in inflammatory bowel disease: Introduction of a new segmentation model.
J Crohns Colitis. 2021 Apr 28. pii: 6257076. doi: 10.1093.
PubMed Abstract available

STRAATMIJER T, Biemans VBC, Hoentjen F, de Boer NKH, et al
Ustekinumab for Crohn's Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study.
J Crohns Colitis. 2021 Apr 28. pii: 6256992. doi: 10.1093.
PubMed Abstract available

OUAHED J, Kelsen JR, Spessott WA, Kooshesh K, et al
Variants in STXBP3 Are Associated With Very Early Onset Inflammatory Bowel Disease, Bilateral Sensorineural Hearing Loss and Immune Dysregulation.
J Crohns Colitis. 2021 Apr 23. pii: 6247960. doi: 10.1093.
PubMed Abstract available

SLEIMAN J, Hitawala AA, Cohen B, Falloon K, et al
Systematic review: Sweet syndrome associated with inflammatory bowel disease.
J Crohns Colitis. 2021 Apr 23. pii: 6247949. doi: 10.1093.
PubMed Abstract available

UNTERWEGER AL, Jensen MO, Giordanetto F, Jogini V, et al
Suppressing Kv1.3 Ion Channel Activity with a Novel Small Molecule Inhibitor Ameliorates Inflammation in a Humanized Mouse Model of Ulcerative Colitis.
J Crohns Colitis. 2021 Apr 23. pii: 6247959. doi: 10.1093.
PubMed Abstract available

PANES J, Vermeire S, Dubinsky MC, Loftus EV, et al
Efficacy and Safety of Tofacitinib Retreatment for Ulcerative Colitis After Treatment Interruption: Results From the OCTAVE Clinical Trials.
J Crohns Colitis. 2021 Apr 22. pii: 6245086. doi: 10.1093.
PubMed Abstract available

CHAPARRO M, Garre A, Iborra M, Sierra M, et al
Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry.
J Crohns Colitis. 2021 Apr 16. pii: 6228235. doi: 10.1093.
PubMed Abstract available

JUNG S, Ye BD, Lee HS, Baek J, et al
Identification of three novel susceptibility loci for inflammatory bowel disease in Koreans in an extended genome-wide association study.
J Crohns Colitis. 2021 Apr 14. pii: 6225940. doi: 10.1093.
PubMed Abstract available

FUMERY M, Yzet C, Chatelain D, Yzet T, et al
Colonic strictures in inflammatory bowel disease: epidemiology, complications, and management.
J Crohns Colitis. 2021 Apr 12. pii: 6222697. doi: 10.1093.
PubMed Abstract available

ATTAR A, Branche J, Coron E, Privat J, et al
An Anti-migration Self-expandable and Removable Metal Stent for Crohn's Disease Strictures: A Nationwide Study From GETAID and SFED.
J Crohns Colitis. 2021;15:521-528.
PubMed Abstract available

NOVAK KL, Nylund K, Maaser C, Petersen F, et al
Expert Consensus on Optimal Acquisition and Development of the International Bowel Ultrasound Segmental Activity Score [IBUS-SAS]: A Reliability and Inter-rater Variability Study on Intestinal Ultrasonography in Crohn's Disease.
J Crohns Colitis. 2021;15:609-616.
PubMed Abstract available

ZHAO J, Wang H, Zhou J, Qian J, et al
miR-130a-3p, a Preclinical Therapeutic Target for Crohn's Disease.
J Crohns Colitis. 2021;15:647-664.
PubMed Abstract available

DE VRIES LCS, Ghiboub M, van Hamersveld PHP, Welting O, et al
Tyrosine Kinase 2 Signalling Drives Pathogenic T cells in Colitis.
J Crohns Colitis. 2021;15:617-630.
PubMed Abstract available

CON D, Parthasarathy N, Bishara M, Luber RP, et al
Development of a Simple, Serum Biomarker-based Model Predictive of the Need for Early Biologic Therapy in Crohn's Disease.
J Crohns Colitis. 2021;15:583-593.
PubMed Abstract available

HUGOT JP, Dumay A, Barreau F, Meinzer U, et al
Crohn's Disease: Is the Cold Chain Hypothesis Still Hot?
J Crohns Colitis. 2021;15:678-686.
PubMed Abstract available

LUND K, Larsen MD, Knudsen T, Kjeldsen J, et al
Infliximab, Immunomodulators and Treatment Failures in Paediatric and Adolescent Patients with Crohn's Disease: a Nationwide Cohort Study.
J Crohns Colitis. 2021;15:575-582.
PubMed Abstract available

VERSTOCKT B, Pouillon L, Bossuyt P
Tofacitinib and Subacute Pneumonitis: Don't Hold Your Breath.
J Crohns Colitis. 2021;15:692-693.
PubMed

RUTKA M, Pigniczki D, Molnar T
Tofacitinib Therapy, the Lender of Last Resort.
J Crohns Colitis. 2021;15:694.
PubMed

D'AMICO F, Guillo L, Baumann C, Danese S, et al
Histological disease activity measured by the Nancy index is associated with long-term outcomes in patients with ulcerative colitis.
J Crohns Colitis. 2021 Apr 5. pii: 6211061. doi: 10.1093.
PubMed Abstract available

NG A
Clinical efficacy of tofacitinib in moderate to severe ulcerative colitis.
J Crohns Colitis. 2021 Apr 5. pii: 6211060. doi: 10.1093.
PubMed

March 2021

BRESSLER B, Yarur A, Silverberg MS, Bassel M, et al
Vedolizumab and Anti-TNFalpha Real-World Outcomes in Biologic-Naive Inflammatory Bowel Disease Patients: Results from the EVOLVE Study.
J Crohns Colitis. 2021 Mar 31. pii: 6205394. doi: 10.1093.
PubMed Abstract available

LANG-SCHWARZ C, Angeloni M, Agaimy A, Atreya R, et al
Validation of the "Inflammatory Bowel Disease - Distribution, Chronicity, Activity (IBD-DCA) Score" for Ulcerative Colitis and Crohn s disease.
J Crohns Colitis. 2021 Mar 27. pii: 6196021. doi: 10.1093.
PubMed Abstract available

PALMIERI C, Muller G, Kroesen AJ, Galata C, et al
Perianal fistula-associated carcinoma in Crohn s disease: a multicenter retrospective case control study.
J Crohns Colitis. 2021 Mar 27. pii: 6189787. doi: 10.1093.
PubMed Abstract available

NORSA L, Berni Canani R, Duclaux-Loras R, Bequet E, et al
Inflammatory bowel disease in patients with congenital chloride diarrhoea.
J Crohns Colitis. 2021 Mar 26. pii: 6189668. doi: 10.1093.
PubMed Abstract available

RUDDY J, Taft T, Keszthelyi D
Gut-Brain Interactions in patients with Inflammatory Bowel Disease (IBD) and the role of Hypnotherapy in Managing Symptoms.
J Crohns Colitis. 2021 Mar 18. pii: 6175701. doi: 10.1093.
PubMed

TORRES J, Halfvarson J, Rodriguez-Lago I, Hedin CRH, et al
Results of the Seventh Scientific Workshop of ECCO: Precision medicine in IBD- prediction and prevention of inflammatory bowel disease.
J Crohns Colitis. 2021 Mar 17. pii: 6175312. doi: 10.1093.
PubMed Abstract available

KUCHARZIK T, Ellul P, Greuter T, Rahier JF, et al
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.
J Crohns Colitis. 2021 Mar 17. pii: 6175313. doi: 10.1093.
PubMed

PIOVANI D, Pansieri C, Kotha SRR, Piazza AC, et al
Ethnic Differences in the Smoking-Related Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
J Crohns Colitis. 2021 Mar 15. pii: 6171987. doi: 10.1093.
PubMed Abstract available

VERSTOCKT B, Verstockt S, Abdu Rahiman S, Ke BJ, et al
Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon.
J Crohns Colitis. 2021;15:485-498.
PubMed Abstract available

COLLARD MK, Benoist S, Maggiori L, Zerbib P, et al
A Reappraisal of Outcome of Elective Surgery After Successful Non-Operative Management of an Intra-Abdominal Abscess Complicating Ileocolonic Crohn's Disease: A Subgroup Analysis of a Nationwide Prospective Cohort.
J Crohns Colitis. 2021;15:409-418.
PubMed Abstract available

RICCIUTO A, Mack DR, Huynh HQ, Jacobson K, et al
Diagnostic Delay Is Associated With Complicated Disease and Growth Impairment in Paediatric Crohn's Disease.
J Crohns Colitis. 2021;15:419-431.
PubMed Abstract available

MOREAU J, Hammoudi N, Marthey L, Trang-Poisson C, et al
Impact of an Education Programme on IBD Patients' Skills: Results of a Randomised Controlled Multicentre Study [ECIPE].
J Crohns Colitis. 2021;15:432-440.
PubMed Abstract available

NARULA N, Wong ECL, Dulai PS, Marshall JK, et al
Week 6 Calprotectin Best Predicts Likelihood of Long-term Endoscopic Healing in Crohn's Disease: A Post-hoc Analysis of the UNITI/IM-UNITI Trials.
J Crohns Colitis. 2021;15:462-470.
PubMed Abstract available

BARELLO S, Guida E, Bonanomi A, Menichetti J, et al
WE-CARE IBD SCORE: Assessing High-quality Care From the Perspective of Patients With Inflammatory Bowel Disease.
J Crohns Colitis. 2021;15:349-357.
PubMed Abstract available

WINTJENS D, Bergey F, Saccenti E, Jeuring S, et al
Disease Activity Patterns of Crohn's Disease in the First Ten Years After Diagnosis in the Population-based IBD South Limburg Cohort.
J Crohns Colitis. 2021;15:391-400.
PubMed Abstract available

FOURIE S, Norton C, Jackson D, Czuber-Dochan W, et al
'These discussions aren't happening'. Experiences of people living with inflammatory bowel disease talking about sexual well-being with healthcare professionals.
J Crohns Colitis. 2021 Mar 4. pii: 6158978. doi: 10.1093.
PubMed Abstract available

PAI RK, Hartman DJ, Leighton JA, Shabana PF, et al
Validated Indices for Histopathologic Activity Predict Development of Colorectal Neoplasia in Ulcerative Colitis.
J Crohns Colitis. 2021 Mar 4. pii: 6158975. doi: 10.1093.
PubMed Abstract available

ATREYA R, Neurath MF
Can Serum Proteomic Profiling Annunciate Individual Disease Progression in Newly Diagnosed Inflammatory Bowel Disease Patients?
J Crohns Colitis. 2021 Mar 2. pii: 6156783. doi: 10.1093.
PubMed

February 2021

LUDVIGSSON JF, Olen O, Larsson H, Halfvarson J, et al
Association between inflammatory bowel disease and psychiatric morbidity and suicide: A Swedish nationwide population-based cohort study with sibling comparisons.
J Crohns Colitis. 2021 Feb 26. pii: 6153473. doi: 10.1093.
PubMed Abstract available

GUILLO L, Peyrin-Biroulet L, Louis E
Tofacitinib De-escalation Strategy in Ulcerative Colitis: Is It the End of the Story?
J Crohns Colitis. 2021 Feb 23. pii: 6146725. doi: 10.1093.
PubMed

ALLIN KH, Jacobsen RK, Ungaro RC, Colombel JF, et al
Bariatric surgery and risk of new-onset inflammatory bowel disease: A nationwide cohort study.
J Crohns Colitis. 2021 Feb 20. pii: 6145790. doi: 10.1093.
PubMed Abstract available

GOETGEBUER RL, Kreijne JE, Aitken CA, Dijkstra G, et al
Increased risk of high-grade cervical neoplasia in women with inflammatory bowel disease: a case-controlled cohort study.
J Crohns Colitis. 2021 Feb 20. pii: 6145789. doi: 10.1093.
PubMed Abstract available

REINISCH W, Sandborn WJ, Danese S, Hebuterne X, et al
Long-term safety and efficacy of the anti-MAdCAM-1 monoclonal antibody ontamalimab (SHP647) for the treatment of ulcerative colitis: the open-label study TURANDOT II.
J Crohns Colitis. 2021 Feb 18. pii: 6144575. doi: 10.1093.
PubMed Abstract available

ARAKI T, Mitsuyama K, Yamasaki H, Morita M, et al
Therapeutic Potential of a Self-Assembling Peptide Hydrogel to Treat Colonic Injuries Associated with Inflammatory Bowel Disease.
J Crohns Colitis. 2021 Feb 17. pii: 6141509. doi: 10.1093.
PubMed Abstract available

ACKERMANN M, Mucci A, McCabe A, Frei S, et al
Restored macrophage function ameliorates disease pathophysiology in a mouse model for IL10 receptor deficient very early onset inflammatory bowel disease.
J Crohns Colitis. 2021 Feb 17. pii: 6141466. doi: 10.1093.
PubMed Abstract available

WATANABE S, Nishimura R, Shirasaki T, Katsukura N, et al
Schlafen 11 is a novel target for mucosal regeneration in Ulcerative Colitis.
J Crohns Colitis. 2021 Feb 17. pii: 6141476. doi: 10.1093.
PubMed Abstract available

ZHAO M, Gonczi L, Lakatos PL, Burisch J, et al
The burden of inflammatory bowel disease in Europe in 2020.
J Crohns Colitis. 2021 Feb 14. pii: 6134782. doi: 10.1093.
PubMed Abstract available

BARNES EL, Holubar SD, Herfarth HH
Systematic Review and Meta-Analysis of Outcomes after Ileal Pouch-Anal Anastomosis in Primary Sclerosing Cholangitis-Ulcerative Colitis.
J Crohns Colitis. 2021 Feb 5. pii: 6129144. doi: 10.1093.
PubMed Abstract available

GHOSH S, Iacucci M
Measuring Patient Experience in Inflammatory Bowel Disease Care: A Key Component of Continuous Quality Improvement.
J Crohns Colitis. 2021 Feb 5. pii: 6129099. doi: 10.1093.
PubMed

January 2021

RUIGROK RAAA, Collij V, Sureda P, Klaassen MAY, et al
The composition and metabolic potential of the human small intestinal microbiota within the context of inflammatory bowel disease.
J Crohns Colitis. 2021 Jan 30. pii: 6123997. doi: 10.1093.
PubMed Abstract available

GRIM C, Noble R, Uribe G, Khanipov K, et al
Impairment of tissue resident mesenchymal stem cells in chronic ulcerative colitis and Crohn's disease.
J Crohns Colitis. 2021 Jan 28. pii: 6121690. doi: 10.1093.
PubMed Abstract available

ALLOCCA M, Bonovas S, Danese S
Letter to the Editor Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound index.
J Crohns Colitis. 2021 Jan 25. pii: 6119566. doi: 10.1093.
PubMed

LOVE BL, Finney CJ, Gaidos JKJ
Effectiveness of Conjugate and Polysaccharide Pneumococcal Vaccines for Prevention of Severe Pneumococcal Disease Among Inflammatory Bowel Disease Patients.
J Crohns Colitis. 2021 Jan 25. pii: 6118663. doi: 10.1093.
PubMed Abstract available

VERMEIRE S, Chiorean M, Panes J, Peyrin-Biroulet L, et al
Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study.
J Crohns Colitis. 2021 Jan 21. pii: 6105062. doi: 10.1093.
PubMed Abstract available

ZAIATZ BITTENCOURT V, Jones F, Tosetto M, Doherty GA, et al
Dysregulation of metabolic pathways in circulating natural killer cells isolated from inflammatory bowel disease patients.
J Crohns Colitis. 2021 Jan 18. pii: 6103919. doi: 10.1093.
PubMed Abstract available

SANDBORN WJ, Feagan BG, Hanauer S, Vermeire S, et al
Long-Term Efficacy And Safety Of Ozanimod In Moderate-To-Severe Ulcerative Colitis: Results From The Open-Label Extension Of The Randomized, Phase 2 Touchstone Study.
J Crohns Colitis. 2021 Jan 13. pii: 6092404. doi: 10.1093.
PubMed Abstract available

EFFENBERGER M, Reider S, Waschina S, Bronowski C, et al
Microbial Butyrate Synthesis Indicates Therapeutic Efficacy of Azathioprine in IBD Patients.
J Crohns Colitis. 2021;15:88-98.
PubMed Abstract available

LEE S, Kuenzig ME, Ricciuto A, Zhang Z, et al
Smoking May Reduce the Effectiveness of Anti-TNF Therapies to Induce Clinical Response and Remission in Crohn's Disease: A Systematic Review and Meta-analysis.
J Crohns Colitis. 2021;15:74-87.
PubMed Abstract available

THOMAS PWA, Ferwerda G, West RL, Hoentjen F, et al
Immediate Infusion Reaction to Intravenous Ustekinumab in Three Crohn's Disease Patients: A Case Report and Review of the Literature.
J Crohns Colitis. 2021;15:162-164.
PubMed Abstract available

WEWER MD, Zhao M, Nordholm-Carstensen A, Weimers P, et al
The Incidence and Disease Course of Perianal Crohn's Disease: A Danish Nationwide Cohort Study, 1997-2015.
J Crohns Colitis. 2021;15:5-13.
PubMed Abstract available

DE CAMPOS RJDS, Lucchetti G, Lucchetti ALG, Chebli LA, et al
Influence of Religiousness and Spirituality on Remission Rate, Mental Health, and Quality of Life of Patients With Active Crohn's Disease: A Longitudinal 2-Year Follow-up Study.
J Crohns Colitis. 2021;15:55-63.
PubMed Abstract available

ZOLLNER A, Schmiderer A, Reider SJ, Oberhuber G, et al
Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study.
J Crohns Colitis. 2021;15:43-54.
PubMed Abstract available

SAEVIK F, Eriksen R, Eide GE, Gilja OH, et al
Development and Validation of a Simple Ultrasound Activity Score for Crohn's Disease.
J Crohns Colitis. 2021;15:115-124.
PubMed Abstract available

D'AMICO F, Nancey S, Danese S, Peyrin-Biroulet L, et al
A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities.
J Crohns Colitis. 2021;15:152-161.
PubMed Abstract available

KUCHARZIK T, Maaser C, Maconi G
A Simple Intestinal Ultrasound Score in Crohn's Disease: First Big Step Towards New Paradigms.
J Crohns Colitis. 2021;15:3-4.
PubMed

MAASER C, Kucharzik T, Gecse K
Is Intestinal Ultrasound Ready to be Used as Standard Monitoring Tool in Daily Practice and as Endpoint in Clinical Trials?
J Crohns Colitis. 2021;15:1-2.
PubMed

DAI C, Jiang M, Huang YH
Anti-Tubercular Therapy on the Long-Term Disease Course of Patients with Crohn's disease.
J Crohns Colitis. 2021;15:169.
PubMed

BARBERIO B, Segal JP, Quraishi MN, Black CJ, et al
Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-Analysis.
J Crohns Colitis. 2021 Jan 12. pii: 6089122. doi: 10.1093.
PubMed Abstract available

DE VOOGD F, Wilkens R, Gecse K, Allocca M, et al
A reliability study - strong inter-observer agreement of an expert panel for intestinal ultrasound in ulcerative colitis.
J Crohns Colitis. 2021 Jan 9. pii: 6073674. doi: 10.1093.
PubMed Abstract available

BOTS S, Nylund K, Lowenberg M, Gecse K, et al
Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound index.
J Crohns Colitis. 2021 Jan 7. pii: 6067606. doi: 10.1093.
PubMed Abstract available

December 2020

VAN DER SLOOT KWJ, Voskuil MD, Blokzijl T, Dinkla A, et al
Isotype specific antibody responses to Mycobacterium Avium subspecies Paratuberculosis antigens are associated with the use of biological therapy in Inflammatory Bowel Disease.
J Crohns Colitis. 2020 Dec 30. pii: 6055607. doi: 10.1093.
PubMed Abstract available

GUILLO L, D'Amico F, Danese S, Peyrin-Biroulet L, et al
Ustekinumab for extra-intestinal manifestations of inflammatory bowel disease: a systematic literature review.
J Crohns Colitis. 2020 Dec 24. pii: 6046385. doi: 10.1093.
PubMed Abstract available

CROUWEL F, Waaijenberg-Warmenhoven P, Buiter HJC, de Boer NK, et al
Recurrent COVID-19 in a patient with ulcerative colitis on vedolizumab therapy.
J Crohns Colitis. 2020 Dec 22. pii: 6044002. doi: 10.1093.
PubMed

RAHMI G, Coron E, Perrod G, Levy M, et al
Probe-based confocal laser endomicroscopy for in vivo assessment of histological healing in ulcerative colitis: development and validation of the ENHANCE index.
J Crohns Colitis. 2020 Dec 18. pii: 6041240. doi: 10.1093.
PubMed Abstract available

BANCIL AS, Sandall AM, Rossi M, Chassaing B, et al
Food additive emulsifiers and their impact on gut microbiome, permeability and inflammation: mechanistic insights in inflammatory bowel disease.
J Crohns Colitis. 2020 Dec 18. pii: 6041235. doi: 10.1093.
PubMed Abstract available

VENTIN-HOLMBERG R, Eberl A, Saqib S, Korpela K, et al
Bacterial and fungal profiles as markers of infliximab drug response in inflammatory bowel disease.
J Crohns Colitis. 2020 Dec 10. pii: 6029424. doi: 10.1093.
PubMed Abstract available

VERMEIRE S, Su C, Lawendy N, Kobayashi T, et al
Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomized RIVETING Trial.
J Crohns Colitis. 2020 Dec 8. pii: 6027842. doi: 10.1093.
PubMed Abstract available

MONSTAD IL, Solberg IC, Cvancarova M, Hovde O, et al
Outcome of Ulcerative Colitis 20 Years after Diagnosis in a Prospective Population-based Inception Cohort from South-Eastern Norway, the IBSEN Study.
J Crohns Colitis. 2020 Dec 2. pii: 6015889. doi: 10.1093.
PubMed Abstract available

November 2020

JOHNSON LE, Lee MJ, Turner-Moore T, Grinsted Tate LR, et al
Systematic review of factors affecting transition readiness skills in patients with inflammatory bowel disease.
J Crohns Colitis. 2020 Nov 30. pii: 6012510. doi: 10.1093.
PubMed Abstract available

HAMAMA-RAZ Y, Nativ S, Hamama L
Posttraumatic Growth in Inflammatory Bowel Disease Patients: The Role of Illness Cognitions and Physical Quality in Life.
J Crohns Colitis. 2020 Nov 30. pii: 6012764. doi: 10.1093.
PubMed Abstract available

TADBIRI S, Nachury M, Bouhnik Y, Serrero M, et al
The IBD-disk is a reliable tool to assess the daily-life burden of patients with inflammatory bowel disease.
J Crohns Colitis. 2020 Nov 27. pii: 6007776. doi: 10.1093.
PubMed Abstract available

WINTHROP KL, Loftus EV Jr, Baumgart DC, Reinisch W, et al
Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme.
J Crohns Colitis. 2020 Nov 27. pii: 6007683. doi: 10.1093.
PubMed Abstract available

VAN DEN BERGHE N, Verstockt B, Gils A, Sabino J, et al
Tissue exposure does not explain non-response in ulcerative colitis patients with adequate serum vedolizumab concentrations.
J Crohns Colitis. 2020 Nov 27. pii: 6007493. doi: 10.1093.
PubMed Abstract available

EVERHOV AH, Bruze G, Soderling J, Askling J, et al
Women's earnings are more affected by inflammatory bowel disease than men's: a register-based Swedish cohort study.
J Crohns Colitis. 2020 Nov 27. pii: 6007494. doi: 10.1093.
PubMed Abstract available

HOEKMAN DR, Vlieger AM, Stokkers PC, Mahhmod N, et al
Hypnotherapy for irritable bowel syndrome-type symptoms in patients with quiescent inflammatory bowel disease: a randomized, controlled trial.
J Crohns Colitis. 2020 Nov 27. pii: 6007495. doi: 10.1093.
PubMed Abstract available

AGRAWAL M, Brenner EJ, Zhang X, Colombel JF, et al
Physician practice patterns on holding inflammatory bowel disease medications due to COVID-19 in the SECURE-IBD registry.
J Crohns Colitis. 2020 Nov 24. pii: 6000079. doi: 10.1093.
PubMed Abstract available

TRAN-MINH ML, Gornet JM, Maillet M, Houze P, et al
Safety of hydrocortisone premedication discontinuation in patients with inflammatory bowel disease on maintenance therapy with Infliximab: a prospective clinical and pharmacological study.
J Crohns Colitis. 2020 Nov 18. pii: 5986749. doi: 10.1093.
PubMed Abstract available

KALLA R, Adams AT, Bergemalm D, Vatn S, et al
Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease.
J Crohns Colitis. 2020 Nov 17. pii: 5985635. doi: 10.1093.
PubMed Abstract available

GALLAGHER K, Catesson A, Griffin JL, Holmes E, et al
Metabolomic Analysis in Inflammatory Bowel Disease: A Systematic Review.
J Crohns Colitis. 2020 Nov 11. pii: 5974408. doi: 10.1093.
PubMed Abstract available

KIM MA, Kim YH, Chun J, Lee HS, et al
The influence of disease activity on pregnancy outcomes in women with inflammatory bowel disease: A systematic review and meta-analysis.
J Crohns Colitis. 2020 Nov 11. pii: 5974276. doi: 10.1093.
PubMed Abstract available

BARBERIO B, Black CJ, Savarino EV, Ford AC, et al
Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis.
J Crohns Colitis. 2020 Nov 11. pii: 5974124. doi: 10.1093.
PubMed Abstract available

SEBASTIAN S, Gonzalez HA, Peyrin-Biroulet L
Safety of Drugs During Previous and Current Coronavirus Pandemics: Lessons for Inflammatory Bowel Disease.
J Crohns Colitis. 2020;14:1632-1643.
PubMed Abstract available

TURSI A, Papa A
Impact of Anti-TNFalpha Antibodies on the Risk of Covid-19 and its Severity in Patients with Inflammatory Bowel Diseases.
J Crohns Colitis. 2020;14:1646-1647.
PubMed

VOSKUIL MD, Spekhorst LM, van der Sloot KWJ, Jansen BH, et al
Genetic risk scores identify genetic aetiology of inflammatory bowel disease phenotypes.
J Crohns Colitis. 2020 Nov 6. pii: 5957220. doi: 10.1093.
PubMed Abstract available

YOKOYAMA Y, Sawada K, Aoyama N, Yoshimura N, et al
Erratum to: Efficacy of Granulocyte and Monocyte Adsorptive Apheresis in Patients With Inflammatory Bowel Disease Showing Lost Response to Infliximab.
J Crohns Colitis. 2020 Nov 6. pii: 5958727. doi: 10.1093.
PubMed

October 2020

MAHMOUD R, van Lieshout C, Frederix GWJ, Jharap B, et al
Continuation of anti-TNF in patients with Ulcerative Colitis in Remission is not Cost-effective compared to Treatment Withdrawal: a Markov Model.
J Crohns Colitis. 2020 Oct 30. pii: 5944009. doi: 10.1093.
PubMed Abstract available

SIEGEL CA, Christensen B, Kornbluth A, Rosh JR, et al
Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19.
J Crohns Colitis. 2020;14.
PubMed Abstract available

LEWIN S, Lees C, Regueiro M, Hart A, et al
International Organization for the Study of Inflammatory Bowel Disease: Global Strategies for Telemedicine and Inflammatory Bowel Diseases.
J Crohns Colitis. 2020;14.
PubMed Abstract available

DE LIMA-KARAGIANNIS A, Juillerat P, Sebastian S, Pedersen N, et al
Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic.
J Crohns Colitis. 2020;14.
PubMed Abstract available

ABREU MT, Peyrin-Biroulet L
Providing Guidance During a Global Viral Pandemic for the Care of Patients With Inflammatory Bowel Disease.
J Crohns Colitis. 2020;14.
PubMed

NG SC, Mak JWY, Hitz L, Chowers Y, et al
COVID-19 Pandemic: Which IBD Patients Need to Be Scoped-Who Gets Scoped Now, Who Can Wait, and how to Resume to Normal.
J Crohns Colitis. 2020;14.
PubMed Abstract available

DOTAN I, Panaccione R, Kaplan GG, O'Morain C, et al
Best Practice Guidance for Adult Infusion Centres during the COVID-19 Pandemic: Report from the COVID-19 International Organization for the Study of IBD [IOIBD] Task Force.
J Crohns Colitis. 2020;14.
PubMed Abstract available

ALLEZ M, Fleshner P, Gearry R, Lakatos PL, et al
Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic.
J Crohns Colitis. 2020;14.
PubMed Abstract available

QURAISHI MN, Iqbal TH, Hart AL
Precision Medicine with FMT for Ulcerative Colitis: Are We There Yet?
J Crohns Colitis. 2020 Oct 20. pii: 5932516. doi: 10.1093.
PubMed

DERIKX LAAP, Lantinga MA, de Jong DJ, van Dop WA, et al
Clinical Outcomes of Covid-19 in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.
J Crohns Colitis. 2020 Oct 20. pii: 5932316. doi: 10.1093.
PubMed Abstract available

BOSSUYT P, Bisschops R, Vermeire S, De Hertogh G, et al
Variability in the distribution of histological disease activity in the colon of patients with ulcerative colitis.
J Crohns Colitis. 2020 Oct 14. pii: 5923369. doi: 10.1093.
PubMed Abstract available

ATTAUABI M, Poulsen A, Theede K, Pedersen N, et al
Prevalence and outcomes of COVID-19 among patients with inflammatory bowel disease - A Danish prospective population-based cohort study.
J Crohns Colitis. 2020 Oct 9. pii: 5920382. doi: 10.1093.
PubMed Abstract available

ALOI M, Bramuzzo M, Norsa L, Arrigo S, et al
Disease activity patterns in the first 5 years after diagnosis in children with ulcerative colitis: a population-based study.
J Crohns Colitis. 2020 Oct 6. pii: 5918427. doi: 10.1093.
PubMed Abstract available

September 2020

MEREDITH J, Khedim CA, Henderson P, Wilson DC, et al
Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in a patient receiving Infliximab therapy for Inflammatory Bowel Disease.
J Crohns Colitis. 2020 Sep 30. pii: 5913452. doi: 10.1093.
PubMed Abstract available

ARHI C, Askari A, Nachiappan S, Bottle A, et al
Stage at diagnosis and survival of colorectal cancer with or without underlying inflammatory bowel disease: a population-based study.
J Crohns Colitis. 2020 Sep 29. pii: 5912977. doi: 10.1093.
PubMed Abstract available

June 2020

D'AMICO F, Baumann C, Rousseau H, Danese S, et al
Phase I, II and III Trials in Inflammatory Bowel Diseases: A Practical Guide for the Non-specialist.
J Crohns Colitis. 2020;14:710-718.
PubMed Abstract available

SOMERS M, Bossuyt P, Ferrante M, Peeters H, et al
Belgian IBD Research Group [BIRD] Position Statement 2019 on the Use of Adalimumab Biosimilars in Inflammatory Bowel Diseases.
J Crohns Colitis. 2020;14:680-685.
PubMed Abstract available

VON MARTELS JZH, Bourgonje AR, Klaassen MAY, Alkhalifah HAA, et al
Riboflavin Supplementation in Patients with Crohn's Disease [the RISE-UP study].
J Crohns Colitis. 2020;14:595-607.
PubMed Abstract available

FAUNY M, D'Amico F, Bonovas S, Netter P, et al
Faecal Calprotectin for the Diagnosis of Bowel Inflammation in Patients With Rheumatological Diseases: A Systematic Review.
J Crohns Colitis. 2020;14:688-693.
PubMed Abstract available

ZHOU C, Wu XR, Liu HS, Liu XH, et al
Immunomodulatory Effect of Urine-derived Stem Cells on Inflammatory Bowel Diseases via Downregulating Th1/Th17 Immune Responses in a PGE2-dependent Manner.
J Crohns Colitis. 2020;14:654-668.
PubMed Abstract available

VALE RODRIGUES R, Sladek M, Katsanos K, van der Woude CJ, et al
Diagnosis and Outcome of Oesophageal Crohn's Disease.
J Crohns Colitis. 2020;14:624-629.
PubMed Abstract available

AL NABHANI Z, Berrebi D, Martinez-Vinson C, Montcuquet N, et al
Nod2 Protects the Gut From Experimental Colitis Spreading to Small Intestine.
J Crohns Colitis. 2020;14:669-679.
PubMed Abstract available

ZHAO M, Burisch J
The Sooner the Better? Cost-effectiveness of Early Biological Therapy in Patients With Crohn's Disease.
J Crohns Colitis. 2020;14:573-574.
PubMed

EDER P, Dobrowolska A, Rydzewska G
Historical Upheavals and Eponyms in Crohn's Disease-Is There Any Relation?
J Crohns Colitis. 2020;14:719.
PubMed

May 2020

NEHRA AK, Sheedy SP, Wells ML, VanBuren WM, et al
Imaging Findings of Ileal Inflammation at Computed Tomography and Magnetic Resonance Enterography: What do They Mean When Ileoscopy and Biopsy are Negative?
J Crohns Colitis. 2020;14:455-464.
PubMed Abstract available

DANIELOU M, Sarter H, Pariente B, Fumery M, et al
Natural History of Perianal Fistulising Lesions in Patients With Elderly-onset Crohn's Disease: A Population-based Study.
J Crohns Colitis. 2020;14:501-507.
PubMed Abstract available

PILLAI N, Lupatsch JE, Dusheiko M, Schwenkglenks M, et al
Evaluating the Cost-Effectiveness of Early Compared with Late or No Biologic Treatment to Manage Crohn's Disease using Real-World Data.
J Crohns Colitis. 2020;14:490-500.
PubMed Abstract available

CONDAMINA M, Diaz E, Jamart C, Loget J, et al
Severe Attack of Henoch-Schonlein Purpura With Neurological Involvement During Adalimumab Treatment for Crohn's Disease.
J Crohns Colitis. 2020;14:538-542.
PubMed Abstract available

SPARROW MP, Papamichael K, Ward MG, Riviere P, et al
Therapeutic Drug Monitoring of Biologics During Induction to Prevent Primary Non-Response.
J Crohns Colitis. 2020;14:542-556.
PubMed Abstract available

RODRIGUEZ-LAGO I, Gisbert JP
The Role of Immunomodulators and Biologics in the Medical Management of Stricturing Crohn's Disease.
J Crohns Colitis. 2020;14:557-566.
PubMed Abstract available

DHALIWAL J, Walters TD, Mack DR, Huynh HQ, et al
Phenotypic Variation in Paediatric Inflammatory Bowel Disease by Age: A Multicentre Prospective Inception Cohort Study of the Canadian Children IBD Network.
J Crohns Colitis. 2020;14:445-454.
PubMed Abstract available

MADARAME A, Kimura H, Kunisaki R
Successful Treatment With Ustekinumab for Enterocutaneous Fistulas in Crohn's Disease.
J Crohns Colitis. 2020;14:569-570.
PubMed

CHATEAU T, Angioi K, Peyrin-Biroulet L
Two Cases of Successful Ustekinumab Treatment for Non-infectious Uveitis Associated With Crohn's Disease.
J Crohns Colitis. 2020;14:571.
PubMed

March 2020

ANNESE V
Small Bowel Adenocarcinoma in Crohn's Disease: An Underestimated Risk?
J Crohns Colitis. 2020;14:285-286.
PubMed

CARBONNEL F, Svrcek M
Progress in the Molecular and Histological Dissection of Crohn's Disease-associated Small Bowel Adenocarcinomas.
J Crohns Colitis. 2020;14:283-284.
PubMed

DELATTRE C, Lewis A, Kirchgesner J, Nion-Larmurier I, et al
Impact of Aphthous Colitis at Diagnosis on Crohn's Disease Outcomes.
J Crohns Colitis. 2020;14:342-350.
PubMed Abstract available

FELWICK RK, Dingley GJR, Martinez-Nunez R, Sanchez-Elsner T, et al
MicroRNA23a Overexpression in Crohn's Disease Targets Tumour Necrosis Factor Alpha Inhibitor Protein 3, Increasing Sensitivity to TNF and Modifying the Epithelial Barrier.
J Crohns Colitis. 2020;14:381-392.
PubMed Abstract available

FIELDS AC, Hu FY, Lu P, Irani J, et al
Small Bowel Adenocarcinoma: Is There a Difference in Survival for Crohn's Versus Sporadic Cases?
J Crohns Colitis. 2020;14:303-308.
PubMed Abstract available

BORREN NZ, Tan W, Colizzo FP, Luther J, et al
Longitudinal Trajectory of Fatigue With Initiation of Biologic Therapy in Inflammatory Bowel Diseases: A Prospective Cohort Study.
J Crohns Colitis. 2020;14:309-315.
PubMed Abstract available

PIOVANI D, Danese S, Peyrin-Biroulet L, Bonovas S, et al
Environmental, Nutritional, and Socioeconomic Determinants of IBD Incidence: A Global Ecological Study.
J Crohns Colitis. 2020;14:323-331.
PubMed Abstract available

FRANZE E, Monteleone I, Laudisi F, Rizzo A, et al
Cadherin-11 Is a Regulator of Intestinal Fibrosis.
J Crohns Colitis. 2020;14:406-417.
PubMed Abstract available

VERSTOCKT B, Mertens E, Dreesen E, Outtier A, et al
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naive and Anti-TNF Exposed IBD Patients.
J Crohns Colitis. 2020;14:332-341.
PubMed Abstract available

POREDSKA K, Kunovsky L, Marek F, Kala Z, et al
The Influence of Microscopic Inflammation at Resection Margins on Early Postoperative Endoscopic Recurrence After Ileocaecal Resection for Crohn's Disease.
J Crohns Colitis. 2020;14:361-368.
PubMed Abstract available

ARPA G, Grillo F, Giuffrida P, Nesi G, et al
Separation of Low- Versus High-grade Crohn's Disease-associated Small Bowel Carcinomas is Improved by Invasive Front Prognostic Marker Analysis.
J Crohns Colitis. 2020;14:295-302.
PubMed Abstract available

PELLINO G, Vinci D, Signoriello G, Kontovounisios C, et al
Long-Term Bowel Function and Fate of the Ileal Pouch After Restorative Proctocolectomy in Patients With Crohn's Disease: A Systematic Review With Meta-Analysis and Metaregression.
J Crohns Colitis. 2020;14:418-427.
PubMed Abstract available

LIAO X, Li G, McBride R, Houldsworth J, et al
Clinicopathological and Molecular Characterisation of Crohn's Disease-associated Small Bowel Adenocarcinomas.
J Crohns Colitis. 2020;14:287-294.
PubMed Abstract available

February 2020

ADAMINA M, Bonovas S, Raine T, Spinelli A, et al
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment.
J Crohns Colitis. 2020;14:155-168.
PubMed Abstract available

MAGRO F, Lopes J, Borralho P, Lopes S, et al
Comparing the Continuous Geboes Score With the Robarts Histopathology Index: Definitions of Histological Remission and Response and their Relation to Faecal Calprotectin Levels.
J Crohns Colitis. 2020;14:169-175.
PubMed Abstract available

WASMANN KA
Complications While Waiting for IBD Surgery-Short Report.
J Crohns Colitis. 2020;14:277-280.
PubMed Abstract available

KEITA AV, Alkaissi LY, Holm EB, Heil SDS, et al
Enhanced E. coli LF82 Translocation through the Follicle-associated Epithelium in Crohn's Disease is Dependent on Long Polar Fimbriae and CEACAM6 expression, and Increases Paracellular Permeability.
J Crohns Colitis. 2020;14:216-229.
PubMed Abstract available

AGRAWAL M, Burisch J, Colombel JF, C Shah S, et al
Viewpoint: Inflammatory Bowel Diseases Among Immigrants From Low- to High-Incidence Countries: Opportunities and Considerations.
J Crohns Colitis. 2020;14:267-273.
PubMed Abstract available

PIERRE N, Salee C, Massot C, Bletard N, et al
Proteomics Highlights Common and Distinct Pathophysiological Processes Associated with Ileal and Colonic Ulcers in Crohn's Disease.
J Crohns Colitis. 2020;14:205-215.
PubMed Abstract available

COSTA-MOREIRA P, Lopes S, Santos AL, Pedrosa AF, et al
Leukocytoclastic Vasculitis Related to Ustekinumab in a Crohn's Disease Patient: First Case Report and Literature Review.
J Crohns Colitis. 2020;14:274-276.
PubMed Abstract available

January 2020

TORRES J, Bonovas S, Doherty G, Kucharzik T, et al
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.
J Crohns Colitis. 2020;14:4-22.
PubMed

TRAVIS S
IM-UNITI at Three Years: Stellar Stelara(R) or Stardust? The Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.
J Crohns Colitis. 2020;14:1-3.
PubMed

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.